| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 2.06e-04 | 30 | 197 | 4 | GO:0052866 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 5-phosphatase activity | 2.51e-04 | 13 | 197 | 3 | GO:0034595 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | TRPM6 TRPM7 CDK12 MAP3K4 MAST4 BUB1 MAP4K4 WNK2 NEK7 PIKFYVE CDK13 MAP3K13 | 2.72e-04 | 363 | 197 | 12 | GO:0106310 |
| GeneOntologyMolecularFunction | histone modifying activity | 4.66e-04 | 229 | 197 | 9 | GO:0140993 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | TRPM6 TRPM7 CDK12 MAP3K4 MAST4 DBF4 BUB1 MAP4K4 WNK2 NEK7 PIKFYVE CDK13 MAP3K13 | 5.07e-04 | 446 | 197 | 13 | GO:0004674 |
| GeneOntologyCellularComponent | Golgi lumen | 9.64e-07 | 109 | 198 | 9 | GO:0005796 | |
| GeneOntologyCellularComponent | anchoring junction | VAPA ZNF384 STARD8 KIAA1210 KIRREL3 FCHSD2 UBN1 FLRT1 MAP4K4 ARHGAP21 JCAD PLXDC1 SH3KBP1 APC SHROOM2 PIKFYVE PLEKHG4B NOX1 SSX2IP CD44 PATJ FYB1 GAB1 PHLDB2 | 1.87e-05 | 976 | 198 | 24 | GO:0070161 |
| GeneOntologyCellularComponent | MLL3/4 complex | 1.73e-04 | 12 | 198 | 3 | GO:0044666 | |
| GeneOntologyCellularComponent | centrosome | CYLD CCP110 RAD18 CEP85L LUZP1 FBXL7 CLIC5 UBN1 ALMS1 RNF19A RBBP6 NEK7 APC SSX2IP CEP295 PATJ GEN1 PCM1 | 4.01e-04 | 770 | 198 | 18 | GO:0005813 |
| GeneOntologyCellularComponent | cell-cell junction | VAPA KIAA1210 KIRREL3 UBN1 FLRT1 JCAD PLXDC1 SH3KBP1 APC SHROOM2 PIKFYVE PLEKHG4B SSX2IP PATJ GAB1 | 5.32e-04 | 591 | 198 | 15 | GO:0005911 |
| Domain | TRPM_tetra | 4.45e-06 | 4 | 195 | 3 | PF16519 | |
| Domain | TRPM_tetra | 4.45e-06 | 4 | 195 | 3 | IPR032415 | |
| Domain | SEA | 7.27e-05 | 22 | 195 | 4 | PF01390 | |
| Domain | SEA | 8.73e-05 | 23 | 195 | 4 | PS50024 | |
| Domain | SEA_dom | 8.73e-05 | 23 | 195 | 4 | IPR000082 | |
| Domain | ZF_CXXC | 1.74e-04 | 11 | 195 | 3 | PS51058 | |
| Domain | Znf_CXXC | 1.74e-04 | 11 | 195 | 3 | IPR002857 | |
| Domain | zf-CXXC | 1.74e-04 | 11 | 195 | 3 | PF02008 | |
| Domain | - | RAD18 TRIM25 MYCBP2 EXPH5 KMT2C KDM2B KMT2A SH3RF1 RNF19A RBBP6 PCLO MSL2 PIKFYVE SCAF11 | 2.76e-04 | 449 | 195 | 14 | 3.30.40.10 |
| Domain | ALMS_motif | 3.23e-04 | 3 | 195 | 2 | IPR029299 | |
| Domain | ALMS_motif | 3.23e-04 | 3 | 195 | 2 | PF15309 | |
| Domain | Znf_RING/FYVE/PHD | RAD18 TRIM25 MYCBP2 EXPH5 KMT2C KDM2B KMT2A SH3RF1 RNF19A RBBP6 PCLO MSL2 PIKFYVE SCAF11 | 3.44e-04 | 459 | 195 | 14 | IPR013083 |
| Domain | SEA | 3.75e-04 | 14 | 195 | 3 | SM00200 | |
| Domain | - | 4.65e-04 | 15 | 195 | 3 | 3.30.70.960 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 2.85e-07 | 26 | 153 | 6 | M27483 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 5.59e-07 | 16 | 153 | 5 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 7.86e-07 | 17 | 153 | 5 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.49e-06 | 21 | 153 | 5 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 4.05e-06 | 23 | 153 | 5 | M556 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CYLD CCP110 GAPVD1 MYCBP2 TRPM7 CEP85L EXPH5 LUZP1 NF1 MAST4 ALMS1 KMT2A MAP4K4 ARHGAP21 DNMT1 JCAD CRTC3 SH3RF1 APC INPP5F MAP7 RFX7 SIPA1L1 SSX2IP USP54 PATJ GEN1 PCM1 GAB1 PHLDB2 | 3.45e-15 | 861 | 201 | 30 | 36931259 |
| Pubmed | CYLD CCP110 EPS8 GAPVD1 LUZP1 NF1 ALMS1 MAP4K4 ANAPC5 JCAD CRTC3 SH3RF1 APC KIAA1549 INPP5F SIPA1L1 SSX2IP CEP295 USP54 PATJ PCM1 PHLDB2 | 2.19e-14 | 446 | 201 | 22 | 24255178 | |
| Pubmed | VAPA CCP110 GAPVD1 MYCBP2 CDK12 NACA FASTKD5 DDB1 ALMS1 ARNT2 RPRD2 MAP4K4 DNMT1 UBE2J1 POLDIP3 CIP2A APC SPG11 ICE1 NUP214 JPH1 PIKFYVE MACO1 CEP295 USP54 PATJ PCM1 | 2.49e-14 | 733 | 201 | 27 | 34672954 | |
| Pubmed | CYLD CCP110 GAPVD1 LUZP1 MAST4 ALMS1 ARHGAP21 CIP2A APC ARHGEF12 MAP7 SIPA1L1 SSX2IP PCM1 GAB1 | 1.72e-12 | 209 | 201 | 15 | 36779422 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CYLD CCP110 EPS8 RAD18 LUZP1 SALL1 UBN1 ALMS1 BUB1 KDM2B SH3RF1 RBBP6 POLDIP3 CIP2A APC MAP7 PIKFYVE WDCP MACO1 PATJ PCM1 GAB1 | 5.36e-12 | 588 | 201 | 22 | 38580884 |
| Pubmed | GAPVD1 CDK12 NACA ANKHD1 KMT2C FBXL7 MAST4 ZNF608 HECW2 KDM2B RPRD2 MAP4K4 WNK2 USP36 KIAA1549 SPG11 ICE1 CACHD1 INPP5F SCAF11 PADI2 | 5.54e-12 | 529 | 201 | 21 | 14621295 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CYLD EPS8 GAPVD1 TRIM25 CEP85L DDB1 LUZP1 PHKB MAST4 ALMS1 MAP4K4 ARHGAP21 BRWD1 JCAD CDV3 CIP2A APC WDCP MACO1 SIPA1L1 ARHGAP12 SSX2IP CEP295 USP54 PCM1 | 3.42e-11 | 853 | 201 | 25 | 28718761 |
| Pubmed | VAPA CYLD RAD18 GATAD2A ATXN7L1 NACA ANKHD1 DDB1 KMT2C SALL1 HOXC11 UBN1 ALMS1 ZNF608 TLE5 KDM2B KMT2A RPRD2 KDM6A RBBP6 POLDIP3 SH3KBP1 NUP214 MAP7 RFX7 LHX1 RIF1 WDCP RFXANK SCAF11 USP54 PCM1 | 5.34e-11 | 1429 | 201 | 32 | 35140242 | |
| Pubmed | CYLD RAD18 GATAD2A ATXN7L1 FASTKD5 ANKHD1 ZC3H3 DDB1 LUZP1 ALMS1 ZNF608 SETSIP RTL9 ANAPC5 BRWD1 USP36 SET RBBP6 KIAA1549 MAP7 JPH1 SIPA1L1 SSX2IP CEP295 USP54 PADI2 PCM1 PHLDB2 | 7.57e-11 | 1116 | 201 | 28 | 31753913 | |
| Pubmed | EXPH5 NCKAP5 MAP3K4 KMT2C TLE5 MAP4K4 WNK2 NUP153 CRTC3 SH3RF1 PNLIP RBBP6 APC NUP214 MUC12 MSL2 RIF1 MUC1 GAB1 | 7.73e-11 | 486 | 201 | 19 | 20936779 | |
| Pubmed | CCP110 STARD8 CMTR1 EXPH5 ZBTB39 ALMS1 TRPM3 ZNF347 ADGRF5 MAML3 SH3RF1 CIP2A COL27A1 MSL2 PIKFYVE NPHP3 CDK13 EEPD1 SSX2IP | 9.84e-11 | 493 | 201 | 19 | 15368895 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | VAPA RAD18 GATAD2A DDB1 FANCA KMT2C ZBTB39 HOXC11 UBN1 KDM2B KMT2A RPRD2 ANAPC5 KDM6A NUP153 DNMT1 USP36 RBBP6 POLDIP3 NUP214 MAP7 RFX7 SRFBP1 MSL2 RIF1 CDK13 RFXANK MACO1 AATF SCAF11 | 1.00e-10 | 1294 | 201 | 30 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GAPVD1 RAD18 MYCBP2 CDK12 NF1 UBN1 DBF4 KDM2B KMT2A MAP4K4 ANAPC5 KDM6A NUP153 DNMT1 RBBP6 NUP214 RFX7 RIF1 CDK13 SIPA1L1 SCAF11 PCM1 PHLDB2 | 1.69e-10 | 774 | 201 | 23 | 15302935 |
| Pubmed | GAPVD1 MYCBP2 ANKHD1 LUZP1 SALL1 ALMS1 ZNF608 BUB1 KDM2B ARHGAP21 CIP2A APC ICE1 NUP214 INPP5F WDCP PCM1 | 4.39e-10 | 418 | 201 | 17 | 34709266 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 6.06e-10 | 18 | 201 | 6 | 18834073 | |
| Pubmed | VAPA EPS8 TRIM25 CDK12 NACA ANKHD1 LUZP1 KMT2C METTL18 KDM2B KMT2A ANAPC5 USP36 FNDC3B SET RBBP6 CDKN2AIP APC ARHGEF12 ICE1 MAP7 SRFBP1 MSL2 RIF1 CDK13 MACO1 SIPA1L1 AATF SCAF11 PATJ | 3.07e-09 | 1497 | 201 | 30 | 31527615 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF384 RAD18 GATAD2A CDK12 LUZP1 SALL1 UBN1 KMT2A RPRD2 NUP153 DNMT1 USP36 RBBP6 POLDIP3 CDKN2AIP ICE1 NUP214 SRFBP1 RIF1 AATF SCAF11 ZNF830 PCM1 | 8.98e-09 | 954 | 201 | 23 | 36373674 |
| Pubmed | CCP110 GATAD2A DDB1 LUZP1 KMT2C ALMS1 RTL9 KMT2A UNC79 KDM6A DNMT1 SET RBBP6 NUP214 CDK13 SCAF11 | 1.74e-08 | 469 | 201 | 16 | 27634302 | |
| Pubmed | GAPVD1 MYCBP2 CDK12 ANKHD1 LUZP1 KMT2C ALMS1 KDM2B KMT2A RPRD2 MAP4K4 KDM6A DNMT1 CDV3 RBBP6 PATJ PCM1 | 2.53e-08 | 549 | 201 | 17 | 38280479 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | MYCBP2 CDK12 F5 NF1 NUP153 USP36 RBBP6 POLDIP3 ARHGEF12 ICE1 MAP7 CDK13 MACO1 PHLDB2 | 2.89e-08 | 361 | 201 | 14 | 26167880 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZNF384 GAPVD1 TRIM25 CDK12 NACA ANKHD1 DDB1 ALMS1 KMT2A RPRD2 ARHGAP21 NUP153 DNMT1 USP36 CDV3 RBBP6 POLDIP3 CDKN2AIP ICE1 NUP214 RIF1 PCM1 | 2.91e-08 | 934 | 201 | 22 | 33916271 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | GATAD2A CDK12 RPRD2 NUP153 DNMT1 SET RBBP6 POLDIP3 SRFBP1 RIF1 SCAF11 ZNF830 | 1.11e-07 | 283 | 201 | 12 | 30585729 |
| Pubmed | MYCBP2 NACA ANKHD1 DDB1 ALMS1 BUB1 ANAPC5 APC NUP214 WDCP SSX2IP | 1.90e-07 | 242 | 201 | 11 | 34011540 | |
| Pubmed | Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma. | 1.90e-07 | 3 | 201 | 3 | 12893366 | |
| Pubmed | CYLD MYCBP2 DDB1 LUZP1 CNTNAP5 NF1 KCNB1 MAP4K4 UNC79 ARHGAP21 WNK2 NUP153 DNMT1 SH3KBP1 APC ARHGEF12 NBEA SIPA1L1 NCAN PCM1 PHLDB2 | 2.20e-07 | 963 | 201 | 21 | 28671696 | |
| Pubmed | CYLD CCP110 TRIM25 CMTR1 MYCBP2 F5 LUZP1 PHKB UBN1 ALMS1 ZNF608 KMT2A CIP2A MAP7 SSX2IP PRDM15 PCM1 | 2.51e-07 | 645 | 201 | 17 | 25281560 | |
| Pubmed | TRPM6 CYLD GAPVD1 RAD18 STARD8 ANKHD1 PHKB KMT2C ANKRD12 ARHGAP21 NUP153 BRWD1 SET APC SHROOM2 NPHP3 SIPA1L1 AATF CIPC CEP295 PATJ GEN1 | 3.76e-07 | 1084 | 201 | 22 | 11544199 | |
| Pubmed | GAPVD1 EXPH5 ALMS1 MAP4K4 ARHGAP21 NUP153 SH3RF1 APC KIAA1549 MACO1 USP54 | 4.34e-07 | 263 | 201 | 11 | 34702444 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | CCP110 CMTR1 MYCBP2 CEP85L FASTKD5 DDB1 TLE5 NUP153 DNMT1 CRTC3 NUP214 MAP7 MACO1 SSX2IP AATF USP54 PCM1 PHLDB2 | 4.65e-07 | 754 | 201 | 18 | 33060197 |
| Pubmed | CYLD ANKHD1 IGSF10 FCHSD2 HECW2 HERC6 KDM6A FNDC3B PLXDC1 PYROXD2 NEK7 ARHGEF12 NPHP3 SSX2IP PADI2 GEN1 GAB1 | 5.89e-07 | 686 | 201 | 17 | 29987050 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | GATAD2A KMT2C SALL1 ZNF608 KDM2B KDM6A DNMT1 JCAD PCLO APC WDCP AATF USP54 | 6.46e-07 | 398 | 201 | 13 | 35016035 |
| Pubmed | SET-NUP214 and MLL cooperatively regulate the promoter activity of the HoxA10 gene. | 7.57e-07 | 4 | 201 | 3 | 34320268 | |
| Pubmed | 7.57e-07 | 4 | 201 | 3 | 25432929 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | VAPA EPS8 F5 PHKB NF1 CAVIN2 DNMT1 APC ARHGEF12 NUP214 SIPA1L1 ARHGAP12 INPP5J PCM1 | 8.08e-07 | 475 | 201 | 14 | 31040226 |
| Pubmed | MYCBP2 LUZP1 PHKB KDM6A NUP153 DNMT1 USP36 JCAD CIP2A CDKN2AIP KIAA1549 NBEA CACHD1 SRFBP1 RIF1 MTMR7 MACO1 SSX2IP CD44 AATF GAB1 | 8.76e-07 | 1049 | 201 | 21 | 27880917 | |
| Pubmed | VAPA GAPVD1 DDB1 MAP4K4 ARHGAP21 NUP153 UBE2J1 SH3RF1 CIP2A APC ARHGEF12 CACHD1 NUP214 JPH1 ARHGAP12 PATJ GAB1 | 9.08e-07 | 708 | 201 | 17 | 39231216 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | VAPA GAPVD1 TRIM25 LUZP1 VSIG10L ARHGAP21 JCAD SH3RF1 CIP2A SH3KBP1 ARHGEF12 NUP214 PATJ GAB1 PHLDB2 | 1.19e-06 | 565 | 201 | 15 | 25468996 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | GAPVD1 EXPH5 DDB1 MAP3K4 KMT2C KMT2A RMND1 MAP4K4 ARHGAP21 CDKN2AIP PCDHB9 NBEA SPG11 NUP214 | 1.38e-06 | 497 | 201 | 14 | 36774506 |
| Pubmed | PCSK5 CDK12 NACA ANKHD1 FANCA BUB1 KMT2A MAP4K4 ANAPC5 ARHGAP21 DNMT1 FNDC3B APC CDK13 WDCP PATJ | 1.40e-06 | 650 | 201 | 16 | 38777146 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TRIM25 SALL1 UBN1 BUB1 WNK2 NUP153 JCAD CRTC3 RBBP6 NUP214 PLEKHG4B PATJ GAB1 | 1.52e-06 | 430 | 201 | 13 | 35044719 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | GAPVD1 LCA5L FANCA IGSF10 KMT2C FBXL7 TRPM3 HECW2 TMEM200C FBXO34 GP1BA CACNA1F PCLO MUC19 NBEA ICE1 CEP295 | 1.54e-06 | 736 | 201 | 17 | 29676528 |
| Pubmed | CYLD MYCBP2 TRPM7 CEP85L NCKAP5 ZNF302 MAP4K4 KDM6A ARHGAP21 DNMT1 BRWD1 JCAD APC NBEA CACHD1 SHROOM2 JPH1 SIPA1L1 CIPC USP54 PADI2 GEN1 PCM1 | 1.73e-06 | 1285 | 201 | 23 | 35914814 | |
| Pubmed | VAPA STARD8 GATAD2A NACA DDB1 KMT2A ARHGAP21 NUP153 SH3KBP1 ARHGEF12 NBEA NUP214 SRFBP1 JPH1 PLEKHG4B RIF1 MACO1 ARHGAP12 PATJ | 1.79e-06 | 916 | 201 | 19 | 32203420 | |
| Pubmed | VAPA CCP110 ZNF384 TRPM7 ATXN7L1 EXPH5 LUZP1 KMT2C NF1 SALL1 CLIC5 KLHL13 BUB1 ANKRD12 CRTC3 SET CDV3 SH3KBP1 APC KCTD17 LIFR FYB1 PCM1 | 1.92e-06 | 1293 | 201 | 23 | 15342556 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | GAPVD1 TRIM25 MYCBP2 MAP3K4 NF1 RPRD2 ANAPC5 NUP153 APC NUP214 WDCP AATF USP54 | 1.96e-06 | 440 | 201 | 13 | 34244565 |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 2.11e-06 | 101 | 201 | 7 | 24613305 | |
| Pubmed | CYLD MAP4K4 ARHGEF12 PIKFYVE WDCP MACO1 SIPA1L1 SSX2IP PCM1 PHLDB2 | 2.27e-06 | 251 | 201 | 10 | 29778605 | |
| Pubmed | TRPM7 FASTKD5 KMT2C NF1 SALL1 UBN1 DBF4 VSIG10L KMT2A MAP4K4 CAVIN2 ATMIN UBE2J1 CDV3 CDKN2AIP SPG11 NUP214 MUC12 PPAT KCTD17 MSL2 CDK13 PCM1 | 2.95e-06 | 1327 | 201 | 23 | 32694731 | |
| Pubmed | 3.76e-06 | 6 | 201 | 3 | 19110483 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.76e-06 | 208 | 201 | 9 | 33230847 | |
| Pubmed | CYLD MAP3K4 KIRREL3 FCHSD2 KLHL13 ANKRD12 ARHGAP21 ATMIN ARHGEF12 NUP214 SIPA1L1 CIPC | 5.01e-06 | 407 | 201 | 12 | 12693553 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 5.51e-06 | 218 | 201 | 9 | 33378226 | |
| Pubmed | 5.55e-06 | 44 | 201 | 5 | 24183668 | ||
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 6.00e-06 | 21 | 201 | 4 | 27626377 | |
| Pubmed | VAPA GAPVD1 TRIM25 TRPM7 LUZP1 NUP153 UBE2J1 CDV3 CIP2A NUP214 JPH1 MACO1 CD44 PCM1 | 6.39e-06 | 568 | 201 | 14 | 37774976 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | EPS8 TRPM7 EXPH5 NF1 MAP4K4 ARHGAP21 KIAA1549 JPH1 NOX1 CD44 PATJ FYB1 GAB1 PHLDB2 | 6.51e-06 | 569 | 201 | 14 | 30639242 |
| Pubmed | VAPA ZNF384 GATAD2A MYCBP2 NACA LUZP1 UBE2J1 POLDIP3 CDKN2AIP CACHD1 NUP214 INPP5F PPAT JPH1 MACO1 SIPA1L1 AATF ZNF830 PCM1 | 6.95e-06 | 1007 | 201 | 19 | 34597346 | |
| Pubmed | 7.11e-06 | 225 | 201 | 9 | 12168954 | ||
| Pubmed | CCP110 RAD18 GATAD2A CDK12 RPRD2 NUP153 RBBP6 APC MAP7 RIF1 CDK13 PCM1 PHLDB2 | 8.33e-06 | 503 | 201 | 13 | 16964243 | |
| Pubmed | 9.41e-06 | 233 | 201 | 9 | 37704626 | ||
| Pubmed | 9.51e-06 | 49 | 201 | 5 | 34368113 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.27e-05 | 184 | 201 | 8 | 32908313 | |
| Pubmed | EPS8 GAPVD1 KMT2C UBN1 TRPM3 RPRD2 FBXO34 CDV3 SH3RF1 POLDIP3 CIP2A APC ARHGAP12 SSX2IP PRDM15 | 1.30e-05 | 689 | 201 | 15 | 36543142 | |
| Pubmed | 1.30e-05 | 133 | 201 | 7 | 15144186 | ||
| Pubmed | UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development. | 1.56e-05 | 9 | 201 | 3 | 23028370 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYCBP2 ATXN7L1 DAB1 ITPK1 PHKB KMT2C ZNF608 TLE5 RPRD2 ANKRD12 KDM6A MAML3 ADGRD1 WNK2 ATMIN SHROOM2 PLEKHG4B CDK13 EEPD1 SCAF11 PATJ PRDM15 PCM1 | 1.89e-05 | 1489 | 201 | 23 | 28611215 |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 1.96e-05 | 95 | 201 | 6 | 29643511 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | VAPA MYCBP2 TRPM7 FASTKD5 DDB1 KBTBD7 LUZP1 ALMS1 BUB1 RMND1 UBE2J1 POLDIP3 CIP2A PCLO PPAT JPH1 PIKFYVE CDK13 MACO1 ARHGAP12 SSX2IP AATF GEN1 | 2.03e-05 | 1496 | 201 | 23 | 32877691 |
| Pubmed | CMTR1 GATAD2A CDK12 NACA DDB1 RPRD2 ARHGAP21 USP36 SET POLDIP3 RIF1 CD44 | 2.19e-05 | 472 | 201 | 12 | 38943005 | |
| Pubmed | GATAD2A NF1 SALL1 KDM2B HERC6 KDM6A UTY MAML3 CAVIN2 JCAD MUC16 NBEA AATF CEP295 | 2.33e-05 | 638 | 201 | 14 | 31182584 | |
| Pubmed | RIN3 NCKAP5 FANCA WNK2 CACNA1F SH3KBP1 NBEA SHROOM2 LEPR FYB1 | 2.41e-05 | 329 | 201 | 10 | 17474147 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | VAPA GAPVD1 GATAD2A CDK12 FASTKD5 LUZP1 MAP3K4 PHKB NF1 BUB1 KMT2A MAP4K4 ANAPC5 ARHGAP21 NEK7 CDK13 MAP3K13 | 2.44e-05 | 910 | 201 | 17 | 36736316 |
| Pubmed | 2.62e-05 | 100 | 201 | 6 | 10048485 | ||
| Pubmed | GAPVD1 MYCBP2 ANKHD1 DDB1 NF1 KMT2A NUP153 DNMT1 POLDIP3 NUP214 RIF1 AATF SCAF11 PCM1 | 3.00e-05 | 653 | 201 | 14 | 22586326 | |
| Pubmed | 3.10e-05 | 103 | 201 | 6 | 10819331 | ||
| Pubmed | EPS8 TRIM25 DDB1 LUZP1 PHKB NF1 HECW2 KMT2A ARHGAP21 WNK2 PCLO SH3KBP1 APC ARHGEF12 KIAA1549 NBEA MAP7 SHROOM2 SIPA1L1 NCAN USP54 PCM1 | 3.11e-05 | 1431 | 201 | 22 | 37142655 | |
| Pubmed | 3.28e-05 | 210 | 201 | 8 | 16565220 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 21720744 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 16194893 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 24858416 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 19149903 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 14976260 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 25531720 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 18608209 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 21602712 | ||
| Pubmed | Suppressive effect of global DNA hypomethylation on gastric carcinogenesis. | 3.32e-05 | 2 | 201 | 2 | 20622006 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 23687433 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 25692682 | ||
| Pubmed | CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. | 3.32e-05 | 2 | 201 | 2 | 20952539 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 22100915 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 24240236 | ||
| Pubmed | Reducing DNA methylation suppresses colon carcinogenesis by inducing tumor cell differentiation. | 3.32e-05 | 2 | 201 | 2 | 25939752 | |
| Pubmed | Msd1/SSX2IP-dependent microtubule anchorage ensures spindle orientation and primary cilia formation. | 3.32e-05 | 2 | 201 | 2 | 24397932 | |
| Pubmed | The channel kinases TRPM6 and TRPM7 are functionally nonredundant. | 3.32e-05 | 2 | 201 | 2 | 16150690 | |
| Pubmed | Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis. | 3.32e-05 | 2 | 201 | 2 | 15942051 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 12538347 | ||
| Pubmed | Human DNA methyltransferase gene DNMT1 is regulated by the APC pathway. | 3.32e-05 | 2 | 201 | 2 | 12538344 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 28220887 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 18434530 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 25561469 | ||
| Interaction | CEP135 interactions | CYLD CCP110 TRPM7 CEP85L LUZP1 ALMS1 RTL9 ARHGAP21 JCAD APC MACO1 SIPA1L1 SSX2IP CEP295 USP54 GEN1 PCM1 PHLDB2 | 1.87e-10 | 272 | 196 | 18 | int:CEP135 |
| Interaction | LATS2 interactions | CYLD CCP110 ALMS1 HERC6 ANAPC5 JCAD APC KIAA1549 NUP214 SIPA1L1 SSX2IP CD44 CEP295 USP54 PATJ PCM1 PHLDB2 | 3.67e-09 | 289 | 196 | 17 | int:LATS2 |
| Interaction | YWHAH interactions | VAPA CYLD CCP110 GAPVD1 RIN3 MYCBP2 TRPM7 CEP85L EXPH5 LUZP1 NF1 MAST4 ALMS1 KMT2A MAP4K4 ARHGAP21 WNK2 DNMT1 JCAD CRTC3 SH3RF1 APC INPP5F MAP7 RFX7 SIPA1L1 SSX2IP USP54 PATJ GEN1 PCM1 GAB1 PHLDB2 | 7.41e-09 | 1102 | 196 | 33 | int:YWHAH |
| Interaction | YWHAG interactions | VAPA CYLD CCP110 GAPVD1 MYCBP2 TRPM7 CEP85L CDK12 EXPH5 LUZP1 NF1 MAST4 ALMS1 KMT2A MAP4K4 ARHGAP21 DNMT1 JCAD CRTC3 SH3RF1 APC INPP5F MAP7 RFX7 SHROOM2 MSL2 SIPA1L1 SSX2IP SCAF11 USP54 PATJ GEN1 PCM1 GAB1 PHLDB2 | 1.29e-08 | 1248 | 196 | 35 | int:YWHAG |
| Interaction | YWHAE interactions | VAPA CYLD GAPVD1 RAD18 TRIM25 MYCBP2 TRPM7 CEP85L CDK12 EXPH5 DDB1 LUZP1 NF1 MAST4 KMT2A ARHGAP21 WNK2 DNMT1 JCAD CRTC3 SH3RF1 PNLIP APC INPP5F MAP7 SHROOM2 MSL2 CDK13 SIPA1L1 SSX2IP SCAF11 USP54 PCM1 GAB1 PHLDB2 | 1.52e-08 | 1256 | 196 | 35 | int:YWHAE |
| Interaction | YWHAZ interactions | VAPA CYLD CCP110 GAPVD1 RIN3 TRIM25 MYCBP2 TRPM7 CEP85L EXPH5 LUZP1 MAP3K4 NF1 MAST4 KMT2A ARHGAP21 WNK2 DNMT1 GP1BA JCAD FNDC3B CRTC3 SH3RF1 APC INPP5F MAP7 MSL2 MACO1 SIPA1L1 SSX2IP SCAF11 USP54 PADI2 PCM1 GAB1 PHLDB2 | 1.55e-08 | 1319 | 196 | 36 | int:YWHAZ |
| Interaction | PHF21A interactions | GAPVD1 MYCBP2 ANKHD1 DDB1 LUZP1 SALL1 ALMS1 BUB1 KDM2B ARHGAP21 CIP2A APC ICE1 NUP214 INPP5F WDCP PCM1 | 4.61e-08 | 343 | 196 | 17 | int:PHF21A |
| Interaction | SYNE3 interactions | VAPA CYLD CCP110 TRPM7 EXPH5 KBTBD7 ALMS1 ARHGAP21 JCAD UBE2J1 APC NUP214 JPH1 WDCP MACO1 SIPA1L1 CEP295 USP54 GEN1 | 7.46e-08 | 444 | 196 | 19 | int:SYNE3 |
| Interaction | FBXO42 interactions | CYLD CCP110 EPS8 DDB1 ALMS1 BUB1 SH3RF1 CIP2A APC MAP7 PIKFYVE MACO1 PCM1 GAB1 | 2.60e-07 | 259 | 196 | 14 | int:FBXO42 |
| Interaction | KCNA3 interactions | VAPA GAPVD1 CMTR1 EXPH5 NACA DDB1 LUZP1 KMT2C KMT2A MAP4K4 ARHGAP21 NUP153 UBE2J1 SH3RF1 RBBP6 CIP2A COL27A1 APC ARHGEF12 CACHD1 NUP214 JPH1 SIPA1L1 ARHGAP12 PATJ GAB1 | 3.71e-07 | 871 | 196 | 26 | int:KCNA3 |
| Interaction | YWHAQ interactions | VAPA CYLD CCP110 RIN3 TRIM25 MYCBP2 TRPM7 CEP85L EXPH5 LUZP1 NF1 MAST4 KMT2A UNC79 ARHGAP21 DNMT1 JCAD CRTC3 SH3RF1 APC INPP5F MAP7 RFX7 MACO1 SIPA1L1 SSX2IP USP54 PCM1 GAB1 PHLDB2 | 4.20e-07 | 1118 | 196 | 30 | int:YWHAQ |
| Interaction | SFN interactions | CYLD CCP110 GAPVD1 TRIM25 MYCBP2 TRPM7 EXPH5 LUZP1 MAST4 ALMS1 KMT2A MAP4K4 ARHGAP21 JCAD CRTC3 SH3RF1 APC INPP5F SIPA1L1 USP54 GAB1 PHLDB2 | 1.13e-06 | 692 | 196 | 22 | int:SFN |
| Interaction | YWHAB interactions | VAPA CYLD CCP110 GAPVD1 RIN3 TRIM25 MYCBP2 TRPM7 CEP85L EXPH5 LUZP1 NF1 MAST4 KMT2A ARHGAP21 CRTC3 SH3RF1 APC INPP5F MAP7 RFX7 SIPA1L1 SSX2IP USP54 PCM1 GAB1 PHLDB2 | 1.97e-06 | 1014 | 196 | 27 | int:YWHAB |
| Interaction | GSK3A interactions | CYLD CCP110 GAPVD1 TRIM25 LUZP1 MAST4 ALMS1 ARHGAP21 CIP2A APC ARHGEF12 MAP7 RFX7 SIPA1L1 SSX2IP PCM1 GAB1 | 3.13e-06 | 464 | 196 | 17 | int:GSK3A |
| Interaction | WWTR1 interactions | GAPVD1 TRIM25 MYCBP2 CDK12 ANKHD1 LUZP1 ALMS1 ARNT2 KMT2A RPRD2 MAP4K4 KDM6A DNMT1 CDV3 PATJ PCM1 | 4.00e-06 | 422 | 196 | 16 | int:WWTR1 |
| Interaction | CFAP184 interactions | CCP110 CEP85L EXPH5 ALMS1 BUB1 ICE1 SSX2IP CEP295 USP54 PCM1 | 4.32e-06 | 162 | 196 | 10 | int:CFAP184 |
| Interaction | ZYX interactions | CYLD CCP110 ZNF384 TRIM25 LUZP1 ALMS1 BUB1 ARHGAP21 SH3RF1 APC PLEKHG4B WDCP SIPA1L1 C17orf78 | 4.42e-06 | 329 | 196 | 14 | int:ZYX |
| Interaction | KDM1A interactions | GAPVD1 TRIM25 MYCBP2 ANKHD1 DDB1 LUZP1 ZBTB39 ALMS1 ZNF608 GABPB2 TLE5 METTL18 BUB1 KDM2B ARHGAP21 DNMT1 TBX5 CIP2A APC ICE1 NUP214 INPP5F WDCP SSX2IP PCM1 | 5.09e-06 | 941 | 196 | 25 | int:KDM1A |
| Interaction | CEP128 interactions | CYLD CCP110 CEP85L LUZP1 ALMS1 ARHGAP21 CIP2A APC SIPA1L1 SSX2IP USP54 PCM1 PHLDB2 | 7.23e-06 | 297 | 196 | 13 | int:CEP128 |
| Interaction | PARD3 interactions | VAPA CYLD TRIM25 MAP4K4 ARHGAP21 JCAD APC KIAA1549 SIPA1L1 USP54 PATJ GAB1 PHLDB2 | 7.50e-06 | 298 | 196 | 13 | int:PARD3 |
| Interaction | CEP120 interactions | 9.27e-06 | 106 | 196 | 8 | int:CEP120 | |
| Interaction | NDC80 interactions | CCP110 TRPM7 CEP85L LUZP1 ALMS1 BUB1 USP36 CIP2A ICE1 SSX2IP CEP295 PCM1 PHLDB2 | 1.22e-05 | 312 | 196 | 13 | int:NDC80 |
| Interaction | AMOT interactions | CYLD CCP110 ALMS1 HECW2 MAP4K4 JCAD APC KIAA1549 RIF1 WDCP SIPA1L1 SSX2IP PATJ | 1.22e-05 | 312 | 196 | 13 | int:AMOT |
| Interaction | GSK3B interactions | CYLD CCP110 GAPVD1 TRIM25 NACA FBXL21P LUZP1 MAP3K4 MAST4 ALMS1 HECW2 ARHGAP21 DNMT1 SET CIP2A APC ARHGEF12 MAP7 SIPA1L1 SSX2IP MUC1 PCM1 GAB1 | 1.31e-05 | 868 | 196 | 23 | int:GSK3B |
| Interaction | SMC5 interactions | ZNF384 RAD18 GATAD2A CDK12 LUZP1 SALL1 UBN1 KMT2A RPRD2 NUP153 DNMT1 USP36 RBBP6 POLDIP3 CIP2A CDKN2AIP ICE1 NUP214 SRFBP1 RIF1 RFXANK AATF SCAF11 ZNF830 PCM1 | 1.44e-05 | 1000 | 196 | 25 | int:SMC5 |
| Interaction | MAPRE3 interactions | CCP110 NCKAP5 LUZP1 MAST4 TLE5 MAP4K4 ARHGAP21 APC MAP7 MACO1 GEN1 | 1.64e-05 | 230 | 196 | 11 | int:MAPRE3 |
| Interaction | CNOT9 interactions | CCP110 RAD18 ANKHD1 SALL1 ALMS1 RPRD2 MAP4K4 APC MACO1 SSX2IP PCM1 | 1.70e-05 | 231 | 196 | 11 | int:CNOT9 |
| Interaction | ODF2 interactions | 2.50e-05 | 158 | 196 | 9 | int:ODF2 | |
| Interaction | RCOR1 interactions | TRIM25 GATAD2A MYCBP2 ANKHD1 LUZP1 SALL1 ALMS1 BUB1 KDM2B ARHGAP21 TBX5 CIP2A APC ICE1 WDCP PCM1 | 2.82e-05 | 494 | 196 | 16 | int:RCOR1 |
| Interaction | DYRK1A interactions | VAPA CYLD RAD18 TRIM25 MYCBP2 ANKHD1 LUZP1 NF1 ANAPC5 NUP153 JCAD ICE1 CACHD1 NUP214 RFX7 SIPA1L1 USP54 | 2.98e-05 | 552 | 196 | 17 | int:DYRK1A |
| Interaction | ZNF330 interactions | ZNF384 RAD18 GATAD2A FASTKD5 SALL1 TLE5 KDM2B KMT2A DNMT1 USP36 SET POLDIP3 SRFBP1 AATF PRDM15 | 3.28e-05 | 446 | 196 | 15 | int:ZNF330 |
| Interaction | BICD1 interactions | CYLD EPS8 TRIM25 LUZP1 BRWD1 JCAD MACO1 ARHGAP12 SSX2IP USP54 PCM1 | 3.53e-05 | 250 | 196 | 11 | int:BICD1 |
| Interaction | MEIS2 interactions | 3.70e-05 | 94 | 196 | 7 | int:MEIS2 | |
| Interaction | CAMSAP2 interactions | 4.24e-05 | 169 | 196 | 9 | int:CAMSAP2 | |
| Interaction | LZTS2 interactions | CYLD CCP110 CEP85L EXPH5 ALMS1 TLE5 ARNT2 POLDIP3 SH3KBP1 APC WDCP SIPA1L1 SSX2IP CEP295 USP54 PHLDB2 | 4.32e-05 | 512 | 196 | 16 | int:LZTS2 |
| Interaction | CCNK interactions | 4.57e-05 | 132 | 196 | 8 | int:CCNK | |
| Interaction | TRPM6 interactions | 4.89e-05 | 8 | 196 | 3 | int:TRPM6 | |
| Interaction | SKAP1 interactions | 6.26e-05 | 102 | 196 | 7 | int:SKAP1 | |
| Interaction | CEP152 interactions | 6.63e-05 | 179 | 196 | 9 | int:CEP152 | |
| Interaction | FBXO22 interactions | CYLD GAPVD1 TRIM25 EXPH5 DDB1 MAP3K4 KMT2C KMT2A RMND1 MAP4K4 ARHGAP21 CDKN2AIP PCDHB9 NBEA SPG11 NUP214 | 8.09e-05 | 540 | 196 | 16 | int:FBXO22 |
| Interaction | PCM1 interactions | VAPA CYLD CCP110 EPS8 MYCBP2 CEP85L LCA5L LUZP1 MAP7 MTMR7 SSX2IP CEP295 ZNF830 PCM1 | 9.40e-05 | 434 | 196 | 14 | int:PCM1 |
| Interaction | ANKUB1 interactions | 9.41e-05 | 2 | 196 | 2 | int:ANKUB1 | |
| Interaction | EN1 interactions | 1.01e-04 | 110 | 196 | 7 | int:EN1 | |
| Interaction | AFDN interactions | TRIM25 KMT2A MAP4K4 ARHGAP21 JCAD APC SIPA1L1 SSX2IP USP54 PATJ GAB1 PHLDB2 | 1.07e-04 | 333 | 196 | 12 | int:AFDN |
| Interaction | CCDC6 interactions | CYLD CCP110 GAPVD1 TRIM25 LUZP1 SH3RF1 APC MAP7 PIKFYVE MTMR7 MACO1 | 1.18e-04 | 286 | 196 | 11 | int:CCDC6 |
| Interaction | OCLN interactions | TRPM7 MAP4K4 ARHGAP21 JCAD APC ARHGEF12 KIAA1549 NBEA CACHD1 JPH1 SIPA1L1 USP54 PATJ GAB1 PHLDB2 | 1.18e-04 | 500 | 196 | 15 | int:OCLN |
| Interaction | TJP2 interactions | KBTBD7 LUZP1 UBN1 ALMS1 ARHGAP21 JCAD SH3KBP1 APC SIPA1L1 ARHGAP12 USP54 | 1.25e-04 | 288 | 196 | 11 | int:TJP2 |
| Interaction | EGLN3 interactions | VAPA CYLD CCP110 GAPVD1 TRIM25 MYCBP2 CDK12 FASTKD5 ANKHD1 DDB1 MAP4K4 ANAPC5 ARHGAP21 NUP153 JCAD CRTC3 CIP2A APC ICE1 CACHD1 PPAT WDCP SSX2IP CEP295 USP54 PCM1 GAB1 | 1.48e-04 | 1296 | 196 | 27 | int:EGLN3 |
| Interaction | VPS33B interactions | 1.49e-04 | 199 | 196 | 9 | int:VPS33B | |
| Interaction | ARHGEF12 interactions | 1.49e-04 | 117 | 196 | 7 | int:ARHGEF12 | |
| Interaction | VASP interactions | CYLD CCP110 TRIM25 DDB1 ALMS1 ARHGAP21 CDV3 ARHGEF12 SIPA1L1 PATJ FYB1 | 1.50e-04 | 294 | 196 | 11 | int:VASP |
| Interaction | SLX4 interactions | ZNF384 TRIM25 CMTR1 ATXN7L1 NACA ANKHD1 DDB1 KBTBD7 SALL1 UBN1 RPRD2 NUP153 USP36 POLDIP3 NUP214 AATF | 1.57e-04 | 572 | 196 | 16 | int:SLX4 |
| Interaction | NINL interactions | CYLD CCP110 NACA DDB1 LUZP1 MAST4 ALMS1 RPRD2 ARHGAP21 SH3RF1 SIPA1L1 CEP295 USP54 PCM1 | 1.65e-04 | 458 | 196 | 14 | int:NINL |
| Interaction | GIPC1 interactions | 1.65e-04 | 119 | 196 | 7 | int:GIPC1 | |
| Interaction | SASS6 interactions | 1.68e-04 | 159 | 196 | 8 | int:SASS6 | |
| Interaction | IRF4 interactions | 1.81e-04 | 85 | 196 | 6 | int:IRF4 | |
| Interaction | PAX2 interactions | 1.81e-04 | 85 | 196 | 6 | int:PAX2 | |
| Interaction | CDH1 interactions | VAPA GAPVD1 TRIM25 LUZP1 ZNF608 BUB1 VSIG10L FLRT1 ARHGAP21 JCAD SET SH3RF1 CIP2A SH3KBP1 ARHGEF12 NUP214 PATJ GAB1 PHLDB2 | 1.87e-04 | 768 | 196 | 19 | int:CDH1 |
| Interaction | GSC interactions | 2.06e-04 | 87 | 196 | 6 | int:GSC | |
| Interaction | SPATA1 interactions | 2.22e-04 | 31 | 196 | 4 | int:SPATA1 | |
| Interaction | NAA40 interactions | ZNF384 GAPVD1 TRIM25 CDK12 NACA ANKHD1 DDB1 ALMS1 KMT2A RPRD2 ARHGAP21 NUP153 DNMT1 USP36 CDV3 RBBP6 POLDIP3 CDKN2AIP ICE1 NUP214 RIF1 PCM1 | 2.23e-04 | 978 | 196 | 22 | int:NAA40 |
| Interaction | SRPK2 interactions | RAD18 TRIM25 MYCBP2 CDK12 F5 ALMS1 TLE5 CAVIN2 USP36 RBBP6 POLDIP3 NEK7 MAP7 CDK13 MACO1 ARHGAP12 AATF SCAF11 | 2.33e-04 | 717 | 196 | 18 | int:SRPK2 |
| Interaction | CEP104 interactions | 2.33e-04 | 89 | 196 | 6 | int:CEP104 | |
| Interaction | FLOT1 interactions | VAPA RAD18 NF1 MAP4K4 ARHGAP21 PCLO APC ARHGEF12 KIAA1549 JPH1 USP54 PATJ GAB1 PHLDB2 | 2.40e-04 | 475 | 196 | 14 | int:FLOT1 |
| Interaction | FOS interactions | CYLD NACA ANKHD1 DDB1 KBTBD7 KMT2C UBN1 TLE5 KDM2B KDM6A SET | 2.51e-04 | 312 | 196 | 11 | int:FOS |
| Interaction | DDX23 interactions | RAD18 TRIM25 CMTR1 CDK12 DDB1 USP36 SET RBBP6 POLDIP3 SRFBP1 CDK13 AATF SCAF11 PCM1 | 2.66e-04 | 480 | 196 | 14 | int:DDX23 |
| Interaction | SRGAP1 interactions | 2.79e-04 | 92 | 196 | 6 | int:SRGAP1 | |
| Interaction | FOXI1 interactions | 2.79e-04 | 92 | 196 | 6 | int:FOXI1 | |
| Interaction | OR51E1 interactions | 2.81e-04 | 3 | 196 | 2 | int:OR51E1 | |
| Interaction | BICD2 interactions | EPS8 TRIM25 LUZP1 MAST4 ALMS1 MAP4K4 NUP153 CDV3 POLDIP3 MACO1 ARHGAP12 USP54 PCM1 | 2.87e-04 | 426 | 196 | 13 | int:BICD2 |
| Interaction | CLK1 interactions | 3.03e-04 | 219 | 196 | 9 | int:CLK1 | |
| Interaction | CDIN1 interactions | 3.20e-04 | 34 | 196 | 4 | int:CDIN1 | |
| Interaction | SOX17 interactions | 3.32e-04 | 95 | 196 | 6 | int:SOX17 | |
| Interaction | TERF2IP interactions | RAD18 CMTR1 GATAD2A CDK12 KBTBD7 ZNF608 KDM2B KMT2A DNMT1 SET RBBP6 RIF1 CDK13 SCAF11 ZNF830 | 3.43e-04 | 552 | 196 | 15 | int:TERF2IP |
| Interaction | S100B interactions | 3.75e-04 | 179 | 196 | 8 | int:S100B | |
| Interaction | LATS1 interactions | CCP110 DDB1 ALMS1 MAP4K4 JCAD APC KIAA1549 RIF1 SIPA1L1 SSX2IP USP54 PATJ PCM1 | 3.90e-04 | 440 | 196 | 13 | int:LATS1 |
| Interaction | NFIX interactions | 3.94e-04 | 227 | 196 | 9 | int:NFIX | |
| Interaction | TUBB4B interactions | CYLD CCP110 RIN3 TRIM25 MYCBP2 ANKHD1 ALMS1 TBX5 USP36 APC NUP214 MAP7 CDK13 SSX2IP PCM1 | 3.99e-04 | 560 | 196 | 15 | int:TUBB4B |
| Interaction | VAV2 interactions | 4.15e-04 | 99 | 196 | 6 | int:VAV2 | |
| Interaction | NUP43 interactions | GATAD2A CDK12 DDB1 ZNF608 KMT2A NUP153 USP36 RBBP6 CDKN2AIP MUC19 APC ICE1 NUP214 MSL2 RIF1 AATF | 4.21e-04 | 625 | 196 | 16 | int:NUP43 |
| Interaction | GOLGA1 interactions | 4.35e-04 | 183 | 196 | 8 | int:GOLGA1 | |
| Interaction | EPB41L4A interactions | 4.47e-04 | 140 | 196 | 7 | int:EPB41L4A | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | 5.34e-05 | 149 | 201 | 6 | chr17q12 | |
| Cytoband | 17q12 | 7.84e-05 | 99 | 201 | 5 | 17q12 | |
| Cytoband | 11q12-q13 | 2.83e-04 | 6 | 201 | 2 | 11q12-q13 | |
| GeneFamily | CD molecules|Mucins | 4.60e-09 | 21 | 124 | 6 | 648 | |
| GeneFamily | Zinc fingers CXXC-type | 6.62e-05 | 12 | 124 | 3 | 136 | |
| GeneFamily | PDZ domain containing | 8.56e-05 | 152 | 124 | 7 | 1220 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.77e-04 | 4 | 124 | 2 | 574 | |
| GeneFamily | F-box and leucine rich repeat proteins | 3.83e-04 | 21 | 124 | 3 | 558 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 5.74e-04 | 24 | 124 | 3 | 485 | |
| GeneFamily | Transient receptor potential cation channels | 9.10e-04 | 28 | 124 | 3 | 249 | |
| GeneFamily | Phosphoinositide phosphatases | 1.35e-03 | 32 | 124 | 3 | 1079 | |
| GeneFamily | VPS9 domain containing | 2.03e-03 | 10 | 124 | 2 | 928 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 4.88e-03 | 50 | 124 | 3 | 721 | |
| Coexpression | GABRIELY_MIR21_TARGETS | GAPVD1 MYCBP2 TRPM7 KBTBD7 ARHGAP21 NEK7 APC ARHGEF12 NBEA SPG11 RFX7 JPH1 LIFR SCAF11 | 5.42e-08 | 289 | 200 | 14 | M2196 |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | CYLD ZNF384 NACA FANCA NF1 HOXC11 KMT2A SET APC ARHGEF12 NUP214 LIFR MUC1 PCM1 | 2.12e-07 | 323 | 200 | 14 | M9150 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CYLD MYCBP2 CEP85L MAST4 KLHL13 ARNT2 KDM2B ANKRD12 UNC79 ADGRD1 BRWD1 PCLO SH3KBP1 MUC19 APC ARHGEF12 KIAA1549 GRID2 NBEA RFX7 SHROOM2 JPH1 LHX1 MACO1 NCAN CBLN2 | 3.66e-07 | 1106 | 200 | 26 | M39071 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CYLD GAPVD1 MYCBP2 CEP85L LUZP1 KMT2C CLIC5 TLE5 KMT2A NUP153 DNMT1 BRWD1 SET CDV3 PLXDC1 RNF19A RBBP6 SH3KBP1 NEK7 SPG11 ICE1 RFX7 PIKFYVE RIF1 CDK13 CD44 SCAF11 FYB1 PCM1 | 3.46e-06 | 1492 | 200 | 29 | M40023 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | CYLD EPS8 RAD18 TMC7 ANKHD1 KIRREL3 ALMS1 ANKRD12 KDM6A ATMIN JCAD CDV3 RBBP6 COL27A1 KIAA1549 GRID2 SHROOM2 NCAN CEP295 PADI2 GEN1 GAB1 PHLDB2 | 1.28e-05 | 1102 | 200 | 23 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | CYLD EPS8 RAD18 TMC7 ANKHD1 KIRREL3 ALMS1 ANKRD12 KDM6A ATMIN JCAD CDV3 RBBP6 COL27A1 KIAA1549 GRID2 SHROOM2 NCAN CEP295 PADI2 GEN1 GAB1 PHLDB2 | 1.75e-05 | 1124 | 200 | 23 | MM1070 |
| Coexpression | GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN | 2.46e-05 | 200 | 200 | 9 | M4828 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | 2.46e-05 | 200 | 200 | 9 | M7500 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_UP | 2.46e-05 | 200 | 200 | 9 | M7516 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP | NCKAP5 PHKB FCHSD2 ARHGAP21 FBXO34 ATMIN ARHGEF12 MAP7 ARHGAP12 | 2.46e-05 | 200 | 200 | 9 | M7978 |
| Coexpression | GSE6875_WT_VS_FOXP3_KO_TREG_UP | 2.46e-05 | 200 | 200 | 9 | M6803 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | EXPH5 FCHSD2 FBXL7 CLIC5 ANKRD12 MAML3 FNDC3B SH3RF1 ARHGEF12 | 3.88e-05 | 212 | 200 | 9 | M39221 |
| Coexpression | NABA_ECM_AFFILIATED | 5.09e-05 | 170 | 200 | 8 | M5880 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 5.35e-05 | 221 | 200 | 9 | M39222 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 6.77e-05 | 177 | 200 | 8 | M39245 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | CCP110 RAD18 FANCA ALMS1 DBF4 ARNT2 UNC79 WNK2 DNMT1 PCDHB9 NBEA PPAT RIF1 MTMR7 GEN1 PCM1 | 7.23e-05 | 680 | 200 | 16 | MM456 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 7.61e-05 | 180 | 200 | 8 | M8239 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 9.03e-05 | 137 | 200 | 7 | M39241 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPS8 GAPVD1 MYCBP2 MAP3K4 FCHSD2 FBXL7 DBF4 ARNT2 NUP153 NEK7 APC SPG11 INPP5F PIKFYVE RIF1 CDK13 SIPA1L1 ARHGAP12 | 1.07e-04 | 856 | 200 | 18 | M4500 |
| Coexpression | DESCARTES_FETAL_PLACENTA_VASCULAR_ENDOTHELIAL_CELLS | 1.34e-04 | 102 | 200 | 6 | M40283 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN | 1.47e-04 | 198 | 200 | 8 | M325 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP | 1.53e-04 | 199 | 200 | 8 | M10018 | |
| Coexpression | GSE18893_TCONV_VS_TREG_24H_CULTURE_DN | 1.58e-04 | 200 | 200 | 8 | M7289 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP | 1.58e-04 | 200 | 200 | 8 | M4262 | |
| Coexpression | GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN | 1.58e-04 | 200 | 200 | 8 | M6989 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | PCSK5 GAPVD1 RAD18 TRPM7 LUZP1 KMT2C MAST4 GABPB2 ANKRD12 FLRT1 ANAPC5 KDM6A UTY CLEC6A SH3RF1 SH3KBP1 PCDHB9 NBEA INPP5F LHX1 LIFR RIF1 MACO1 SCAF11 CEP295 | 1.29e-07 | 801 | 198 | 25 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CEP85L CDK12 DAB1 LUZP1 MAP3K4 ALMS1 DBF4 BUB1 FLRT1 MAML3 DNMT1 PCLO MAP7 RFX7 RIF1 MACO1 SCAF11 GEN1 JHY | 6.34e-07 | 532 | 198 | 19 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | PCSK5 GAPVD1 RAD18 TRPM7 CDK12 KMT2C MAST4 ANKRD12 FLRT1 ANAPC5 KDM6A UTY CAVIN2 CLEC6A SH3RF1 SH3KBP1 PCDHB9 NBEA LHX1 RIF1 MACO1 SCAF11 CEP295 | 1.41e-06 | 790 | 198 | 23 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NCKAP5 ANKHD1 LUZP1 SALL1 CLIC5 ALMS1 DBF4 FLRT1 ANAPC5 KDM6A MAML3 ARHGAP21 WNK2 BRWD1 CDV3 RBBP6 PCLO MAP7 PPAT LHX1 RIF1 NCAN CEP295 GEN1 PCM1 JHY | 1.85e-06 | 989 | 198 | 26 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | STARD8 CMTR1 CEP85L PLPPR3 LUZP1 FANCA FCHSD2 CLIC5 MAML3 BRWD1 UBE2J1 CACNA1F SET CDV3 PCLO APC ARHGEF12 MAP7 MSL2 LHX1 RIF1 CEP295 MUC6 PCM1 JHY | 5.89e-06 | 989 | 198 | 25 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | CCP110 RAD18 DAB1 NCKAP5 SALL1 ALMS1 ZNF608 BUB1 OR1G1 KDM2B CDV3 RBBP6 PCLO PCDHB9 ARHGEF12 CACHD1 MAP7 LHX1 DDIAS SIPA1L1 GEN1 | 7.43e-06 | 749 | 198 | 21 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | CMTR1 CEP85L PLPPR3 LUZP1 FANCA FCHSD2 CLIC5 MAML3 BRWD1 UBE2J1 APC MSL2 RIF1 CEP295 PCM1 | 1.40e-05 | 432 | 198 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | CCP110 TMC7 GANC TRPM7 DAB1 NCKAP5 ALMS1 DBF4 KLHL13 ARNT2 BUB1 WNK2 BRWD1 UBE2J1 SET CIP2A APC KIAA1549 RIF1 WDCP SSX2IP CEP295 MUC1 GEN1 PCM1 | 1.91e-05 | 1060 | 198 | 25 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | CCP110 TMC7 GANC TRPM7 DAB1 NCKAP5 SALL1 HOXC11 CLIC5 ALMS1 DBF4 KLHL13 ARNT2 BUB1 HERC6 WNK2 BRWD1 UBE2J1 SET CIP2A APC KIAA1549 LHX1 RIF1 WDCP SSX2IP CEP295 MUC1 GEN1 PCM1 | 2.02e-05 | 1414 | 198 | 30 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | VAPA MYCBP2 CDK12 DAB1 SALL1 CLIC5 ARNT2 RNF19A APC MAP7 LHX1 WDCP PATJ MUC1 | 2.64e-05 | 402 | 198 | 14 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | GANC NCKAP5 ANKHD1 LUZP1 PHKB CLIC5 ALMS1 DBF4 ANAPC5 KDM6A ARHGAP21 FBXO34 RBBP6 PCLO SH3KBP1 NEK7 JPH1 RIF1 CEP295 GEN1 PCM1 | 3.47e-05 | 831 | 198 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | VAPA EPS8 CEP85L DAB1 CNTNAP5 TLE5 HECW2 KLHL13 SIGLEC10 RMND1 KDM6A MAML3 ARHGAP21 CRTC3 PNLIP PLXDC1 RNF19A MUC16 CACHD1 PATJ | 5.35e-05 | 791 | 198 | 20 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | VAPA MYCBP2 CDK12 DAB1 ARNT2 BRWD1 SH3RF1 RNF19A APC KIAA1549 NUP214 WDCP MUC1 | 6.01e-05 | 379 | 198 | 13 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | PCSK5 GAPVD1 RAD18 TRPM7 ANKHD1 MAST4 GABPB2 ANAPC5 KDM6A UTY NUP153 SH3RF1 PLXDC1 CIP2A SH3KBP1 LHX1 RIF1 MACO1 SCAF11 CEP295 | 6.92e-05 | 806 | 198 | 20 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CCP110 RAD18 GANC TRPM7 LCA5L SALL1 ALMS1 KLHL13 ARNT2 BUB1 KDM2B ANKDD1B HERC6 KDM6A ARHGAP21 WNK2 BRWD1 UBE2J1 SET CIP2A APC SHROOM2 MTMR7 NPHP3 ARHGAP12 CEP295 GEN1 PCM1 | 7.56e-05 | 1370 | 198 | 28 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_100 | 9.62e-05 | 79 | 198 | 6 | gudmap_developingKidney_e15.5_Podocyte cells_100 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CCP110 RAD18 TRPM7 CEP85L DAB1 FASTKD5 LUZP1 CLIC5 ALMS1 DBF4 BUB1 ANKDD1B ARHGAP21 DNMT1 BRWD1 SET RBBP6 CIP2A APC KIAA1549 RIF1 CIPC SCAF11 CEP295 GEN1 PCM1 | 1.15e-04 | 1257 | 198 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | CYLD GAPVD1 RAD18 CDK12 ANKHD1 KMT2C STRADB MAST4 ALMS1 GABPB2 BUB1 ANKRD12 KDM6A NUP153 PLXDC1 CIP2A RIF1 CD44 CEP295 | 1.26e-04 | 776 | 198 | 19 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | CEP85L CDK12 LUZP1 FCHSD2 ALMS1 BUB1 MAP4K4 MAML3 APC RFX7 RIF1 SCAF11 GEN1 JHY | 1.37e-04 | 469 | 198 | 14 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ANKHD1 LUZP1 CLIC5 ALMS1 KDM6A ARHGAP21 RBBP6 RIF1 CEP295 GEN1 PCM1 | 1.71e-04 | 311 | 198 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | VAPA MYCBP2 CDK12 DAB1 MEP1A SALL1 CLIC5 ARNT2 BRWD1 SH3RF1 RNF19A APC KIAA1549 NUP214 MAP7 LHX1 WDCP PATJ MUC1 | 1.71e-04 | 795 | 198 | 19 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | CCP110 RAD18 DAB1 ALMS1 ZNF608 BUB1 KDM2B RBBP6 LHX1 DDIAS GEN1 | 1.96e-04 | 316 | 198 | 11 | gudmap_kidney_P3_CapMes_Crym_k4_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.39e-04 | 221 | 198 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | GAPVD1 RAD18 TRPM7 KMT2C MAST4 GABPB2 ANKRD12 KDM6A INPP5F CEP295 | 2.71e-04 | 275 | 198 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | PCSK5 RAD18 TRPM7 MAST4 GABPB2 UTY SH3RF1 PLXDC1 LHX1 RIF1 SCAF11 CEP295 | 4.22e-04 | 403 | 198 | 12 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000 | MYCBP2 CDK12 DAB1 MFSD6L F5 FANCA CLIC5 RNF19A NEK7 APC NUP214 MAP7 LHX1 LIFR WDCP PATJ MUC1 PADI2 | 4.25e-04 | 786 | 198 | 18 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | DAB1 ZBTB39 SALL1 CLIC5 ARNT2 ADGRF5 HERC6 CAVIN2 DNMT1 SET CLEC6A PYROXD2 KIAA1549 LEPR LHX1 CEP295 PATJ FYB1 GEN1 | 4.26e-04 | 855 | 198 | 19 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 4.55e-04 | 192 | 198 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | CCP110 RAD18 ALMS1 DBF4 BUB1 NUP153 CIP2A MUC19 PPAT SRFBP1 LHX1 DDIAS RIF1 MTMR7 MACO1 SSX2IP AATF FYB1 | 4.86e-04 | 795 | 198 | 18 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 4.87e-04 | 148 | 198 | 7 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CCP110 RAD18 TRPM7 CEP85L DAB1 FASTKD5 LUZP1 SALL1 CLIC5 ALMS1 DBF4 BUB1 ANKDD1B ARHGAP21 DNMT1 BRWD1 SET RBBP6 CIP2A APC KIAA1549 RIF1 CIPC SCAF11 CEP295 GEN1 PCM1 | 5.02e-04 | 1459 | 198 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | PCSK5 TRPM7 KMT2C MAST4 ANKRD12 ANAPC5 KDM6A UTY CAVIN2 SH3RF1 COL27A1 SH3KBP1 PCDHB9 LHX1 RIF1 CD44 SCAF11 CEP295 | 5.15e-04 | 799 | 198 | 18 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | GAPVD1 RAD18 TRPM7 MAST4 GABPB2 KLHL13 ANKRD12 ANAPC5 KDM6A NUP153 SH3RF1 PNLIP PLXDC1 CIP2A RIF1 MACO1 SCAF11 CEP295 | 5.54e-04 | 804 | 198 | 18 | gudmap_developingGonad_e12.5_ovary_1000 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 ZC3H3 DDB1 KMT2C KCNB1 KMT2A UTY PCLO NBEA RIF1 SCAF11 PCM1 PHLDB2 | 5.90e-12 | 195 | 201 | 13 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | EPS8 MAST4 ZNF608 ADGRF5 WNK2 CACHD1 MAP7 PLEKHG4B MAP3K13 USP54 PATJ MUC1 | 5.39e-11 | 185 | 201 | 12 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | CDK12 LUZP1 CLIC5 ALMS1 ANKRD12 RBBP6 APC ARHGEF12 SRFBP1 SCAF11 CEP295 | 9.30e-10 | 186 | 201 | 11 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | EPS8 EXPH5 MAST4 CLIC5 ADGRF5 SH3RF1 MAP7 MAP3K13 USP54 PATJ MUC1 | 1.04e-09 | 188 | 201 | 11 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 ZC3H3 KMT2C KCNB1 KMT2A UTY PCLO NBEA RIF1 PCM1 PHLDB2 | 1.53e-09 | 195 | 201 | 11 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | EPS8 EXPH5 NCKAP5 MAST4 CLIC5 ADGRF5 SH3RF1 MAP7 USP54 PATJ MUC1 | 1.53e-09 | 195 | 201 | 11 | 9406866f99555198a9be311fbd65751b70f35446 |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | EPS8 MAST4 CLIC5 ZNF608 ARHGEF12 CACHD1 MAP7 LIFR MAP3K13 PATJ | 5.77e-09 | 170 | 201 | 10 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CEP85L SALL1 CLIC5 ZNF608 ADGRF5 CAVIN2 JCAD APC LIFR PHLDB2 | 1.37e-08 | 186 | 201 | 10 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | EPS8 MAST4 CLIC5 ZNF608 ADGRF5 SH3RF1 MAP7 MAP3K13 USP54 PATJ | 1.44e-08 | 187 | 201 | 10 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | EXPH5 MAST4 ZNF608 ADGRF5 SH3RF1 CACHD1 MAP7 MAP3K13 USP54 PATJ | 1.76e-08 | 191 | 201 | 10 | e432c6e1ae82dddf84314ce73d2b7a991630d905 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | MAST4 CLIC5 ZNF608 ADGRF5 CACHD1 MAP7 JPH1 MAP3K13 USP54 PATJ | 1.76e-08 | 191 | 201 | 10 | ca5669bd6f4a17471acae3eb229f845cc2e08efa |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | MAST4 CLIC5 ZNF608 ADGRF5 SH3RF1 CACHD1 JPH1 MAP3K13 USP54 PATJ | 1.76e-08 | 191 | 201 | 10 | d3733c8c4bda70c4390e5601fdda6188a64be944 |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | NCKAP5 FBXL7 MAST4 ZNF608 HECW2 ADGRF5 JCAD CACHD1 LEPR LIFR | 1.94e-08 | 193 | 201 | 10 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | NCKAP5 KMT2C MAST4 ZNF608 KMT2A ADGRF5 BRWD1 ARHGEF12 LEPR LIFR | 2.72e-08 | 200 | 201 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-07 | 180 | 201 | 9 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-07 | 180 | 201 | 9 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | NCKAP5 SLC36A2 MAST4 TRPM3 UNC79 COL27A1 KIAA1549 ZNF804B MAP3K13 | 1.43e-07 | 181 | 201 | 9 | 9542c19edc9bd2cba68c01c2a8407705398e3011 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | NCKAP5 SLC36A2 MAST4 TRPM3 UNC79 COL27A1 KIAA1549 ZNF804B MAP3K13 | 1.43e-07 | 181 | 201 | 9 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.43e-07 | 181 | 201 | 9 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.50e-07 | 182 | 201 | 9 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.73e-07 | 185 | 201 | 9 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.73e-07 | 185 | 201 | 9 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.81e-07 | 186 | 201 | 9 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 1.89e-07 | 187 | 201 | 9 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-07 | 188 | 201 | 9 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-07 | 188 | 201 | 9 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-07 | 188 | 201 | 9 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | NCKAP5 SLC36A2 MAST4 TRPM3 COL27A1 KIAA1549 ZNF804B MAP3K13 PATJ | 1.98e-07 | 188 | 201 | 9 | f3edcefeef2ce19086032d98b243c02a6d542b38 |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.98e-07 | 188 | 201 | 9 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | NCKAP5 SLC36A2 MAST4 TRPM3 COL27A1 KIAA1549 ZNF804B MAP3K13 PATJ | 1.98e-07 | 188 | 201 | 9 | 0792432cd4c564dea1102241ea9884f7ced7658c |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 2.17e-07 | 190 | 201 | 9 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 2.26e-07 | 191 | 201 | 9 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.26e-07 | 191 | 201 | 9 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 2.26e-07 | 191 | 201 | 9 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.37e-07 | 192 | 201 | 9 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-07 | 192 | 201 | 9 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 2.37e-07 | 192 | 201 | 9 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.37e-07 | 192 | 201 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 2.47e-07 | 193 | 201 | 9 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.47e-07 | 193 | 201 | 9 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-07 | 194 | 201 | 9 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.58e-07 | 194 | 201 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-07 | 194 | 201 | 9 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.07e-07 | 198 | 201 | 9 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.20e-07 | 199 | 201 | 9 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.20e-07 | 199 | 201 | 9 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.20e-07 | 199 | 201 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 3.34e-07 | 200 | 201 | 9 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.34e-07 | 200 | 201 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.09e-06 | 170 | 201 | 8 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.09e-06 | 170 | 201 | 8 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-06 | 177 | 201 | 8 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.47e-06 | 177 | 201 | 8 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 178 | 201 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.60e-06 | 179 | 201 | 8 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-06 | 180 | 201 | 8 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 181 | 201 | 8 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.74e-06 | 181 | 201 | 8 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.81e-06 | 182 | 201 | 8 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-06 | 184 | 201 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 2.05e-06 | 185 | 201 | 8 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-06 | 185 | 201 | 8 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.13e-06 | 186 | 201 | 8 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-06 | 187 | 201 | 8 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.22e-06 | 187 | 201 | 8 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 2.31e-06 | 188 | 201 | 8 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-06 | 189 | 201 | 8 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-06 | 189 | 201 | 8 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-06 | 189 | 201 | 8 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-06 | 189 | 201 | 8 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-06 | 190 | 201 | 8 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-06 | 190 | 201 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.60e-06 | 191 | 201 | 8 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 2.60e-06 | 191 | 201 | 8 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.70e-06 | 192 | 201 | 8 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.70e-06 | 192 | 201 | 8 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-06 | 192 | 201 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-06 | 192 | 201 | 8 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.81e-06 | 193 | 201 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-06 | 193 | 201 | 8 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|IPF / Disease state, Lineage and Cell class | 2.92e-06 | 194 | 201 | 8 | 169a304d5c13f08c39fad4116f093bc4a0765e9d | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.92e-06 | 194 | 201 | 8 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.92e-06 | 194 | 201 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 194 | 201 | 8 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.92e-06 | 194 | 201 | 8 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.92e-06 | 194 | 201 | 8 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 195 | 201 | 8 | 52b2bbf12e5f86c493f6634697aeb23a68cc916d | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.03e-06 | 195 | 201 | 8 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 195 | 201 | 8 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.15e-06 | 196 | 201 | 8 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.27e-06 | 197 | 201 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-06 | 197 | 201 | 8 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-06 | 197 | 201 | 8 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 3.27e-06 | 197 | 201 | 8 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.39e-06 | 198 | 201 | 8 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-06 | 198 | 201 | 8 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.52e-06 | 199 | 201 | 8 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 3.52e-06 | 199 | 201 | 8 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.52e-06 | 199 | 201 | 8 | 0075bcc7d2a5031e76a24cb176e16ac998d846fd | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.52e-06 | 199 | 201 | 8 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| Drug | Idoxuridine [54-42-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | ATXN7L1 ITPK1 NF1 HOXC11 HERC6 UBE2J1 APC ARHGEF12 SHROOM2 INPP5J JHY | 1.12e-06 | 194 | 198 | 11 | 4200_UP |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | CYLD CCP110 ALMS1 ANKRD12 BRWD1 PCLO PIKFYVE SSX2IP CD44 SCAF11 | 7.07e-06 | 191 | 198 | 10 | 4168_DN |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; HL60; HG-U133A | 7.75e-06 | 193 | 198 | 10 | 1417_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; PC3; HG-U133A | LUZP1 HOXC11 MAST4 CLIC5 KMT2A UTY ARHGEF12 SHROOM2 SSX2IP CD44 | 1.06e-05 | 200 | 198 | 10 | 665_DN |
| Drug | cellobiitol | 1.64e-05 | 37 | 198 | 5 | CID000003871 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.70e-05 | 178 | 198 | 9 | 3998_DN | |
| Drug | Dedb | 3.51e-05 | 8 | 198 | 3 | CID000133794 | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 4.88e-05 | 192 | 198 | 9 | 3612_DN | |
| Drug | AG-028671 [847803-03-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.08e-05 | 193 | 198 | 9 | 6587_UP | |
| Drug | 5248896; Up 200; 11uM; MCF7; HT_HG-U133A_EA | 5.28e-05 | 194 | 198 | 9 | 955_UP | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 5.28e-05 | 194 | 198 | 9 | 4422_DN | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 5.50e-05 | 195 | 198 | 9 | 6259_UP | |
| Drug | Orlistat; Up 200; 10uM; MCF7; HT_HG-U133A | 5.50e-05 | 195 | 198 | 9 | 6415_UP | |
| Drug | 6-mercaptopurine monohydrate; Down 200; 10uM; PC3; HG-U133A | 5.50e-05 | 195 | 198 | 9 | 667_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 5.72e-05 | 196 | 198 | 9 | 2229_DN | |
| Drug | Deferoxamine mesylate [138-14-7]; Down 200; 6uM; PC3; HT_HG-U133A | 5.72e-05 | 196 | 198 | 9 | 3760_DN | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 5.72e-05 | 196 | 198 | 9 | 3324_DN | |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; PC3; HT_HG-U133A | 5.95e-05 | 197 | 198 | 9 | 4622_UP | |
| Drug | Etoposide [33419-42-0]; Up 200; 6.8uM; PC3; HT_HG-U133A | 5.95e-05 | 197 | 198 | 9 | 6681_UP | |
| Drug | Nicergoline; Down 200; 8.2uM; MCF7; HT_HG-U133A | 5.95e-05 | 197 | 198 | 9 | 6251_DN | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 6.19e-05 | 198 | 198 | 9 | 7232_UP | |
| Drug | Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 6.19e-05 | 198 | 198 | 9 | 6246_DN | |
| Drug | rofecoxib; Up 200; 10uM; MCF7; HG-U133A | 6.19e-05 | 198 | 198 | 9 | 256_UP | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; PC3; HT_HG-U133A | 6.19e-05 | 198 | 198 | 9 | 3663_UP | |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; PC3; HT_HG-U133A | 6.19e-05 | 198 | 198 | 9 | 4667_UP | |
| Drug | Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A | 6.19e-05 | 198 | 198 | 9 | 5837_UP | |
| Drug | Epitiostanol [2363-58-8]; Up 200; 13uM; PC3; HT_HG-U133A | 6.43e-05 | 199 | 198 | 9 | 4204_UP | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; PC3; HT_HG-U133A | 6.43e-05 | 199 | 198 | 9 | 4261_DN | |
| Drug | Isometheptene mucate; Down 200; 8.2uM; MCF7; HT_HG-U133A | 6.43e-05 | 199 | 198 | 9 | 5502_DN | |
| Drug | Contact Lens Solutions | 7.52e-05 | 2 | 198 | 2 | ctd:D018639 | |
| Drug | dibromsalan | 7.52e-05 | 2 | 198 | 2 | CID000014839 | |
| Drug | APCP | 7.52e-05 | 2 | 198 | 2 | CID003083759 | |
| Disease | Kabuki syndrome (implicated_via_orthology) | 1.22e-04 | 3 | 189 | 2 | DOID:0060473 (implicated_via_orthology) | |
| Disease | X-12093 measurement | 1.22e-04 | 3 | 189 | 2 | EFO_0021285 | |
| Disease | Polyposis, Adenomatous Intestinal | 1.36e-04 | 16 | 189 | 3 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 1.36e-04 | 16 | 189 | 3 | C2713443 | |
| Disease | Adenomatous Polyposis Coli | 1.65e-04 | 17 | 189 | 3 | C0032580 | |
| Disease | Malignant neoplasm of breast | STARD8 CEP85L PHKB NF1 RMND1 ANAPC5 DNMT1 FNDC3B NUP214 SHROOM2 LEPR RIF1 WDCP SIPA1L1 MAP3K13 USP54 GEN1 GAB1 | 2.01e-04 | 1074 | 189 | 18 | C0006142 |
| Disease | Brooke-Spiegler syndrome | 2.43e-04 | 4 | 189 | 2 | C1857941 | |
| Disease | pulse pressure measurement | RIN3 GATAD2A TRPM7 ANKUB1 LCA5L LUZP1 FBXL7 TRPM3 DNMT1 TBX5 USP36 JCAD FNDC3B COL27A1 NEK7 ARHGEF12 NBEA SRFBP1 EEPD1 ARHGAP12 PCM1 | 2.48e-04 | 1392 | 189 | 21 | EFO_0005763 |
| Disease | coronary artery disease | TRPM7 CDK12 DAB1 ITPK1 IGSF10 MAST4 CLIC5 TRPM3 RPRD2 ARHGAP21 WNK2 JCAD FNDC3B CDKN2AIP ARHGEF12 SRFBP1 MSL2 SCAF11 MUC1 | 2.56e-04 | 1194 | 189 | 19 | EFO_0001645 |
| Disease | hypertrophic cardiomyopathy | 3.20e-04 | 92 | 189 | 5 | EFO_0000538 | |
| Disease | mean platelet volume | RIN3 STARD8 CDK12 NACA FANCA MAST4 UBN1 TRPM3 TLE5 ADGRF5 CAVIN2 FBXO34 GP1BA JCAD SET SH3KBP1 LEPR | 3.23e-04 | 1020 | 189 | 17 | EFO_0004584 |
| Disease | non-arteritic anterior ischemic optic neuropathy (is_implicated_in) | 4.03e-04 | 5 | 189 | 2 | DOID:0050864 (is_implicated_in) | |
| Disease | N2-acetyl,N6-methyllysine measurement | 4.03e-04 | 5 | 189 | 2 | EFO_0800109 | |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 4.03e-04 | 5 | 189 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | Ovarian Serous Adenocarcinoma | 4.17e-04 | 23 | 189 | 3 | C1335177 | |
| Disease | Colonic Neoplasms | 4.56e-04 | 152 | 189 | 6 | C0009375 | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 4.74e-04 | 24 | 189 | 3 | DOID:1184 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 5.23e-04 | 156 | 189 | 6 | DOID:10283 (is_marker_for) | |
| Disease | neuroimaging measurement, brain volume measurement | 5.42e-04 | 286 | 189 | 8 | EFO_0004346, EFO_0006930 | |
| Disease | Malignant tumor of colon | 5.79e-04 | 159 | 189 | 6 | C0007102 | |
| Disease | Hereditary Diffuse Gastric Cancer | 6.35e-04 | 293 | 189 | 8 | C1708349 | |
| Disease | electrocardiography | MYCBP2 CEP85L DAB1 LUZP1 MAST4 TRPM3 TBX5 JCAD FNDC3B SIPA1L1 MUC1 | 6.59e-04 | 530 | 189 | 11 | EFO_0004327 |
| Disease | osteoarthritis, hip, osteoarthritis, knee | 6.81e-04 | 62 | 189 | 4 | EFO_0004616, EFO_1000786 | |
| Disease | Stomach Neoplasms | 6.93e-04 | 297 | 189 | 8 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 7.40e-04 | 300 | 189 | 8 | C0024623 | |
| Disease | chronic mucus hypersecretion | 8.39e-04 | 7 | 189 | 2 | EFO_0005673 | |
| Disease | tissue factor pathway inhibitor measurement | 8.39e-04 | 7 | 189 | 2 | EFO_0007968 | |
| Disease | MASA syndrome (implicated_via_orthology) | 8.39e-04 | 7 | 189 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | Leukemia, Myelocytic, Acute | 8.99e-04 | 173 | 189 | 6 | C0023467 | |
| Disease | white matter microstructure measurement | NCKAP5 ANKHD1 FBXL7 MAST4 ARHGAP21 CDKN2AIP MSL2 JPH1 MAP3K13 | 9.75e-04 | 390 | 189 | 9 | EFO_0005674 |
| Disease | blood nickel measurement | 1.07e-03 | 120 | 189 | 5 | EFO_0007583 | |
| Disease | fructose-1-phosphate measurement, glucose-6-phosphate measurement, fructose-6-phosphate measurement, glucose-1-phosphate measurement | 1.11e-03 | 8 | 189 | 2 | EFO_0010478, EFO_0010479, EFO_0010484, EFO_0010485 | |
| Disease | N2,N2-dimethylguanosine measurement | 1.11e-03 | 8 | 189 | 2 | EFO_0021125 | |
| Disease | Parkinson disease | 1.14e-03 | 321 | 189 | 8 | MONDO_0005180 | |
| Disease | Abnormality of radial ray | 1.22e-03 | 33 | 189 | 3 | C4228778 | |
| Disease | pentachlorophenol measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022071 | |
| Disease | parathion measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022070 | |
| Disease | potassium chromate measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022067 | |
| Disease | methoxychlor measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022055 | |
| Disease | aldrin measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022054 | |
| Disease | dicofol measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022060 | |
| Disease | disulfoton measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022062 | |
| Disease | dieldrin measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022061 | |
| Disease | endrin measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022064 | |
| Disease | endosulfan measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022063 | |
| Disease | heptachlor measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022066 | |
| Disease | ethion measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022056 | |
| Disease | diazinon measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0022058 | |
| Disease | environmental exposure measurement | 1.26e-03 | 73 | 189 | 4 | EFO_0008360 | |
| Disease | platelet crit | RIN3 GATAD2A EXPH5 ITPK1 PHKB NF1 MAST4 RPRD2 GP1BA JCAD ARHGEF12 LEPR CDK13 NCAN FYB1 | 1.27e-03 | 952 | 189 | 15 | EFO_0007985 |
| Disease | Acute Myeloid Leukemia, M1 | 1.29e-03 | 125 | 189 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.29e-03 | 125 | 189 | 5 | C1879321 | |
| Disease | puberty onset measurement | 1.29e-03 | 125 | 189 | 5 | EFO_0005677 | |
| Disease | DDT metabolite measurement | 1.32e-03 | 74 | 189 | 4 | EFO_0007886 | |
| Disease | heart function measurement | 1.34e-03 | 34 | 189 | 3 | EFO_0004311 | |
| Disease | PR interval | MYCBP2 CEP85L DAB1 NCKAP5 TRPM3 DBF4 TBX5 FNDC3B SIPA1L1 PHLDB2 | 1.41e-03 | 495 | 189 | 10 | EFO_0004462 |
| Disease | Lynch Syndrome | 1.43e-03 | 9 | 189 | 2 | C4552100 | |
| Disease | Adenoma, Microcystic | 1.58e-03 | 36 | 189 | 3 | C0205648 | |
| Disease | Adenoma, Monomorphic | 1.58e-03 | 36 | 189 | 3 | C0205649 | |
| Disease | Adenoma, Basal Cell | 1.58e-03 | 36 | 189 | 3 | C0205646 | |
| Disease | Follicular adenoma | 1.58e-03 | 36 | 189 | 3 | C0205647 | |
| Disease | Papillary adenoma | 1.58e-03 | 36 | 189 | 3 | C0205650 | |
| Disease | Adenoma, Trabecular | 1.58e-03 | 36 | 189 | 3 | C0205651 | |
| Disease | Adenoma | 1.58e-03 | 36 | 189 | 3 | C0001430 | |
| Disease | hip circumference | 1.58e-03 | 338 | 189 | 8 | EFO_0005093 | |
| Disease | comparative body size at age 10, self-reported | 1.63e-03 | 420 | 189 | 9 | EFO_0009819 | |
| Disease | intraocular pressure measurement | PCSK5 KBTBD7 FANCA CLIC5 KMT2A JCAD FNDC3B PCLO ARHGEF12 NPHP3 | 1.73e-03 | 509 | 189 | 10 | EFO_0004695 |
| Disease | vitamin B6 measurement | 1.78e-03 | 10 | 189 | 2 | EFO_0004621 | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] measurement | 1.78e-03 | 10 | 189 | 2 | EFO_0800499 | |
| Disease | dry eye syndrome (is_marker_for) | 1.78e-03 | 10 | 189 | 2 | DOID:10140 (is_marker_for) | |
| Disease | age at onset, multiple sclerosis | 1.78e-03 | 10 | 189 | 2 | EFO_0004847, MONDO_0005301 | |
| Disease | C-reactive protein measurement | FANCA SALL1 ZNF608 KDM2B MAP4K4 ANAPC5 MAML3 ARHGAP21 NEK7 SPG11 CACHD1 LEPR MSL2 EEPD1 SCAF11 PATJ FYB1 | 2.02e-03 | 1206 | 189 | 17 | EFO_0004458 |
| Disease | hormone measurement | 2.11e-03 | 84 | 189 | 4 | EFO_0004730 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 2.11e-03 | 84 | 189 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 2.12e-03 | 140 | 189 | 5 | C0005695 | |
| Disease | UDP-glucuronic acid decarboxylase 1 measurement | 2.16e-03 | 11 | 189 | 2 | EFO_0803221 | |
| Disease | Malignant neoplasm of urinary bladder | 2.19e-03 | 141 | 189 | 5 | C0005684 | |
| Disease | lung adenocarcinoma (is_marker_for) | 2.20e-03 | 85 | 189 | 4 | DOID:3910 (is_marker_for) | |
| Disease | Carcinoma, Transitional Cell | 2.31e-03 | 41 | 189 | 3 | C0007138 | |
| Disease | venous thromboembolism, response to antineoplastic agent | 2.31e-03 | 41 | 189 | 3 | EFO_0004286, GO_0097327 | |
| Disease | oral microbiome measurement | 2.47e-03 | 42 | 189 | 3 | EFO_0801229 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.50e-03 | 364 | 189 | 8 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | methionine sulfone measurement | 2.58e-03 | 12 | 189 | 2 | EFO_0800072 | |
| Disease | hemorrhoid | 2.62e-03 | 147 | 189 | 5 | EFO_0009552 | |
| Disease | schizophrenia, type 2 diabetes mellitus | 2.64e-03 | 43 | 189 | 3 | MONDO_0005090, MONDO_0005148 | |
| Disease | nasopharyngeal neoplasm | 2.94e-03 | 151 | 189 | 5 | EFO_0004252 | |
| Disease | venous thromboembolism | 2.99e-03 | 460 | 189 | 9 | EFO_0004286 | |
| Disease | QRS complex, QRS duration | 3.01e-03 | 45 | 189 | 3 | EFO_0005054, EFO_0005055 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 3.01e-03 | 45 | 189 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | body surface area | PCSK5 LUZP1 ITPK1 UBN1 ZNF608 ACAN UNC79 DNMT1 FNDC3B ARHGEF12 PATJ | 3.03e-03 | 643 | 189 | 11 | EFO_0022196 |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 3.04e-03 | 13 | 189 | 2 | C1846647 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 3.04e-03 | 13 | 189 | 2 | EFO_0802114 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VAHSDKPGSTSTASF | 206 | Q9P0L0 | |
| FHLSDTVPASSASKN | 481 | Q5SNV9 | |
| PSTHSKTSAVSSQAN | 586 | Q9NYV4 | |
| SSKTSPDISHQQAAA | 116 | Q9N2K0 | |
| KVANTSSFHTTPNTS | 431 | O43683 | |
| STRQTTITSHFAKGP | 161 | P26358 | |
| LTSSSARTSNAKPFH | 826 | Q6QNK2 | |
| SSIPLSKNVHSFFSA | 41 | Q9Y2D8 | |
| ETCKASHITSSVFPS | 36 | Q9NWN3 | |
| SHITSSVFPSASLGK | 41 | Q9NWN3 | |
| ADQKTATPTVLSSSH | 561 | Q8TCU4 | |
| AAQKTGTPTVSSNSH | 941 | Q8TCU4 | |
| VSSVKSSDSPTQHAV | 301 | Q5VU97 | |
| SSCHLIPTSKFQTGS | 111 | Q8N4C9 | |
| HSSFATSPTGASNSK | 1366 | Q6UB98 | |
| HVSDFSTDNSGSQPK | 491 | Q9UBU7 | |
| SDTQFPSLQSTAKHV | 191 | Q9UKY7 | |
| TTSSSLTDPHAGVKA | 1286 | Q14004 | |
| PSPSSFTIQHSKAFS | 136 | Q9NZA1 | |
| SSKGSSAQHSPSSLR | 101 | Q7L9B9 | |
| SHNAVSSLPLSFDKS | 761 | Q9ULK2 | |
| LASTADSKHTFSPVI | 1066 | Q9NZN5 | |
| SKTQSSPFGIGTSHT | 591 | Q9HBZ2 | |
| TSVTNHFSQSKLDSP | 396 | Q9NS91 | |
| DSSKTSELHSNSALP | 386 | Q9HCM3 | |
| SDSFSGTEPEVHKTS | 116 | Q9UJX4 | |
| SAADGTPKHSFRTSS | 376 | Q9P2P5 | |
| DNEFSTIATSHPKSV | 511 | Q9Y5S8 | |
| FVSPSLAVHKSSSAV | 596 | Q86YP4 | |
| QTHTKRSTFDTFPQA | 686 | O60840 | |
| VKTTFSSSTPSTHLF | 846 | Q8WXI7 | |
| ESQSSVPADSHTSKA | 5731 | Q8WXI7 | |
| GSTHLLQSSKTDFTS | 10191 | Q8WXI7 | |
| SKTTPNFFHSELDTV | 10611 | Q8WXI7 | |
| QAHSSFSTNKTPTSL | 1511 | Q6W4X9 | |
| FSTNKTPTSLHSHTS | 1516 | Q6W4X9 | |
| TLQKHKSSSSFTPFI | 846 | O95819 | |
| SPLSNHSTEKDSAAS | 261 | Q8NHA8 | |
| NSHNVSKPESSSVLT | 231 | Q13572 | |
| PHTLNSTSTSKSFQS | 4726 | Q8NEZ4 | |
| TPTHSFLARSKSTAA | 231 | Q14244 | |
| KFHSSSDSQTVRASP | 546 | Q6NUN7 | |
| TSSVSSPVKFTHDIS | 176 | Q8NCT3 | |
| SSAEHSLGSLKPTST | 91 | Q8N387 | |
| SQESASVKSDPSHSP | 351 | Q96JK9 | |
| SIDKFTTHITQFATP | 2376 | Q2M2H8 | |
| EPSKHSGFSTSDNSI | 561 | Q9Y216 | |
| GTLKPDSTHSNEFDS | 391 | P16233 | |
| PTRTHADSAKSTSSE | 196 | Q13480 | |
| KGHRSLSPSSNSAFS | 751 | Q9P266 | |
| VAAPHSSSSSPSKDS | 941 | Q14C86 | |
| AVHTKTDNSVASSPS | 806 | O15550 | |
| DGSSQSSSALVHKPS | 571 | Q9HDC5 | |
| TPTTLASHSTKTDAS | 1001 | P15941 | |
| SASFVSLLKSSVNSH | 241 | Q9NXV6 | |
| SPSSNSVSKSHVSEP | 646 | Q5VYM1 | |
| HSATNGSIPSSSSKN | 336 | Q8N5G2 | |
| TSAQESASSHPAKRT | 131 | Q8IWD5 | |
| TDDDSPHKQFSTSSI | 886 | O43424 | |
| VSFSHASSSARTKPT | 4326 | Q9Y6V0 | |
| PTVNQHETSTSKSVF | 796 | Q15154 | |
| PATEHFKTALFITSS | 1736 | Q92824 | |
| TVSAASTTSSPVSKH | 1971 | Q7Z5P9 | |
| STTSSPVSKHTDAAS | 1976 | Q7Z5P9 | |
| PVSKHTDAASATAVT | 1981 | Q7Z5P9 | |
| FSSKTTAAHSLVGTP | 186 | Q8TDX7 | |
| SVSFKHSQDLGSPKS | 146 | A6NFA0 | |
| EPLESSNTKSFHSAV | 346 | Q8IXT1 | |
| VDLTKFHKTSSGNST | 366 | O15117 | |
| FRKEPSSVTTHSSDG | 866 | Q8TET4 | |
| TTHQDTSSTRAPGKT | 361 | Q8IVU3 | |
| FTAAQGATPSTKESS | 1236 | P35658 | |
| SLHFPATTQSKSGFI | 341 | Q8NEV8 | |
| PSQASTSHAFGDSKV | 636 | O95447 | |
| TAVEPKFNSSGTHFS | 66 | P48357 | |
| KENSLHSATTGSDPS | 126 | P48742 | |
| FPGENIVSKSFSSHS | 141 | O95568 | |
| SPLTSFAHTKTVTSS | 371 | Q8WVZ9 | |
| SAAPAGAQTFSLKHS | 31 | Q9Y2J8 | |
| IPSATGHQKTFSTCA | 226 | Q8NH79 | |
| HSTPNGLSSESSRKT | 196 | Q8N5Z5 | |
| SPVTTFLAASTHDDK | 551 | Q9HCI7 | |
| THTPQLFESSGKVST | 2061 | P16112 | |
| HDSTRASSNKDFTPN | 1456 | Q7Z6E9 | |
| ESSPSSPKHQDTASS | 446 | Q8IWW6 | |
| SSPSTHSAQKDTVAS | 261 | P47890 | |
| SSSPHLPFSESKTFN | 11 | O43283 | |
| NSDPFAHSKDASSTS | 1166 | Q9Y2I7 | |
| SVHTQTFLPSSKVTS | 456 | O43313 | |
| TSSAHPGLEFSKTSS | 71 | Q7L8L6 | |
| TAETSVKPSVSAFTH | 1381 | Q6WRI0 | |
| EKSPFRETTGSSSHA | 1301 | Q9Y2F5 | |
| SKAGPTRIFTSNTHS | 61 | Q9P2N7 | |
| ASQHSSFFIESPKSS | 646 | Q14721 | |
| KRASSLQTSPGSSSH | 816 | Q8NHM5 | |
| RQSSPSKSSASHASD | 521 | O75553 | |
| PKEDSHSTTGTAAAS | 416 | P16070 | |
| SDVSSSTDHTPTKAQ | 21 | Q9UJT9 | |
| NSDSALHTSALSTKP | 161 | Q6UUV7 | |
| SVKGSCSEPVSFTTH | 361 | Q53EP0 | |
| SHLTSNSTTDLPKAF | 1271 | O15360 | |
| AKVAFSATRSTNHEP | 91 | Q8IUK8 | |
| VEDHSTSSGTLSFKP | 76 | Q5SZL2 | |
| SFPSHTEHSTAAKLD | 126 | O43303 | |
| HPTQKTAPSSFTKSA | 386 | Q8IZC6 | |
| SKSHIPGSETDRTFS | 2056 | Q9NSI6 | |
| KTTRTFSDTTHGSVP | 506 | Q86V48 | |
| TNPSSSGSAHSVAKE | 206 | O43248 | |
| SLHPTQESTKEQTTF | 341 | P07359 | |
| STDNSSKPSSEPASH | 1051 | O15021 | |
| KSLISESSQPNTSSH | 561 | Q17RS7 | |
| NTFKEHHSTPTISLS | 641 | Q8IZU9 | |
| AHSPTSFTESSSKES | 2096 | Q03164 | |
| ALPHKSLTATQSFSE | 346 | Q9ULL0 | |
| PTFSQTDREHGSKTS | 26 | Q12929 | |
| HASATTPQGSLFTLK | 371 | Q9NZU1 | |
| FPSNGSSLCKATHTI | 611 | Q9NZU1 | |
| EKSLHAESPGFSQAS | 686 | O94868 | |
| SSSHNKPKATGSTSD | 331 | Q9NQC7 | |
| TSNHQKISSGKSSPF | 276 | O95810 | |
| QHTFTSLPSADTKSG | 1001 | Q9C0D2 | |
| SFPTKSNDTLPSSHR | 1566 | Q9C0D2 | |
| TFKLPSNSLGFTATH | 621 | Q5VT52 | |
| PTSTISFEHFGTSCK | 271 | Q99590 | |
| AHSVASQKTPTSASS | 1031 | Q9Y2H2 | |
| PSSEKVASSAGASHV | 351 | Q9NSC2 | |
| SSSKLFSSSTAPHET | 766 | Q16531 | |
| TTVHSSSDPFGKTDE | 1211 | Q8WYK1 | |
| PSSVSHGAKASTTSL | 36 | Q8N1G2 | |
| AAFTQKFSSSIAPHI | 786 | Q93100 | |
| TINSLHDFGSSTSKF | 111 | P42702 | |
| ALFKSSGASVTTQPT | 401 | Q9BY77 | |
| FSDQGPAHLTTSKSA | 6 | Q96KF2 | |
| ASVSSPQAGSSLKHS | 56 | O14593 | |
| QATAHSQSSPEFKGS | 516 | Q8TB24 | |
| TISSNSFFHIKISGS | 171 | Q9Y5E1 | |
| QSATSSFKSTHPDLI | 91 | Q9UKT6 | |
| KSISSAHDTRGSSVP | 1216 | Q9Y6R4 | |
| TNTKTTSGDPHASTV | 201 | Q8TAK5 | |
| STSHINITASGSKPT | 1106 | Q8NET4 | |
| FNSPTVHAFTVKGTS | 4011 | O75445 | |
| TKTDHSVASSPSSAI | 756 | O14607 | |
| HRVPTTANSSSSGSK | 96 | A6NKL6 | |
| KVASNHSPFSSESRA | 266 | Q99593 | |
| KNSVLNSSTAEHSSP | 816 | P12259 | |
| SQSLKSQPLSSSFHD | 106 | Q6ZQX7 | |
| TQHPSTFETSSTSKL | 1431 | O14513 | |
| KAPSRHSSSGDTFSL | 1301 | Q7Z494 | |
| SSPSFFSKHANTLIT | 466 | Q5UIP0 | |
| TTTDTSSVPKFTHHQ | 691 | P57071 | |
| STSNIFAATGATPKS | 1821 | Q8NFP9 | |
| TSPAQVNKAEHSSSS | 711 | O14594 | |
| VFTTSKSHTSPAIND | 526 | Q16819 | |
| FDSVVSSTEKLSHPT | 466 | Q96B97 | |
| LLKSEDSHPFSNSTT | 466 | Q495M3 | |
| TPESQKSFKFHALSS | 1551 | O43166 | |
| FHLNESGDPSSKSTK | 166 | P0DME0 | |
| FHLNESGDPSSKSTE | 156 | Q01105 | |
| SSSTPDHTLSKADTS | 216 | Q13796 | |
| HFSSVSTETFVPKQD | 126 | Q9NWS8 | |
| FREHTGKPTTSSSEA | 4341 | O75592 | |
| RKKTTSSISPHFSSA | 901 | Q86SQ0 | |
| HSPATSEKVSKASSF | 151 | Q92502 | |
| SAAAQSSTAPKHSDT | 281 | Q7Z6J0 | |
| SHSAKTPGFSVQSIS | 141 | Q9NY61 | |
| PSTGFTLTFKQDHSL | 406 | A6NHY2 | |
| TFHTGSSSLPAAKEV | 601 | Q8IZF2 | |
| TPASTKSIHANFSSG | 1781 | Q8IWZ3 | |
| IVERTPFSSSSSSKH | 2756 | P25054 | |
| DSTESSGTQSPKRHS | 2821 | P25054 | |
| KSSFSSFLEHSGKTP | 476 | A6NFN9 | |
| QSSNHSFPTSIKCLT | 571 | Q8TCG1 | |
| VSSSHVAKAPSLTFA | 246 | Q9C0C6 | |
| HSSLTCFSEGTKVPA | 61 | Q6EIG7 | |
| SSHLPQQLKFTTSDS | 11 | Q08117 | |
| TPEGQKTATAHRSSS | 91 | Q15735 | |
| FNPSSKSSVSDQFDH | 556 | Q96JI7 | |
| SKSDQLTPHSQASVT | 71 | Q8TF68 | |
| SEASSKDHASQLSPV | 396 | Q8IXZ2 | |
| KSNIHLSDVDFTPTS | 326 | A4D1E1 | |
| HTTKSPTDTFGTINF | 86 | Q9BX84 | |
| ESKPSKFRHNSGSSS | 621 | Q9NV58 | |
| SLSQNRTPSKTSSHS | 661 | B3KS81 | |
| FRKSTTQASSHNPGE | 146 | Q9BW04 | |
| SSATTHGASIFTEKT | 296 | Q8N2H3 | |
| KTFPSQHATLSAFAA | 201 | Q6T4P5 | |
| ESVFFHSLSGSKSSR | 341 | Q8NEF9 | |
| PVHTKSSTSSSLNDT | 221 | Q8NI35 | |
| GSTAVSSSDHAAPFK | 1171 | Q96PX9 | |
| SISKHTQLSPTDAFG | 126 | Q9HCF6 | |
| EAAAKATSSHPNSTS | 421 | Q14258 | |
| VTSDGSSVPTFKSHK | 51 | Q06203 | |
| SSGKTISESDLNHSF | 191 | Q9Y385 | |
| THTGPSNRFKTDFLS | 1646 | P21359 | |
| SNSNTPLKHSASVSS | 386 | Q2KHR2 | |
| PLKHSASVSSATGTT | 391 | Q2KHR2 | |
| HTATSSKKPAFNLSA | 221 | P49790 | |
| AKPLTSTSESHSGTL | 131 | O15060 | |
| GKPFSICSSLTTHQT | 796 | Q96SE7 | |
| NNPFASSISKHGVSS | 901 | Q9NPG3 | |
| STTAQSSQLKESHSP | 981 | Q9ULD9 | |
| KEASQGSSASSAPHS | 86 | Q96NB3 | |
| NSDRLHTPSSKTFSP | 326 | Q9C0K7 | |
| SSSQHPVKTGLSDAF | 246 | Q8IUK5 | |
| SPESKFSAETHSAAS | 176 | Q86VR7 | |
| KVPTISVTSFHSQSS | 1901 | Q9Y3S1 | |
| SFSHSPGAVSSLKVF | 686 | Q9H6R7 | |
| SSQGTKPTTSHFSVL | 186 | Q96LC7 | |
| ESFTSSPLSDVNLSH | 126 | Q8WUA8 | |
| THVTKPSFSQKSFVS | 631 | Q5T5U3 | |
| STSPETKHSEFLANV | 1566 | Q5T5U3 | |
| TSSSTPQLRKSHESF | 551 | Q96QT4 | |
| EHSASSDSTKAPQTP | 616 | Q9P275 | |
| KTVSTFPSSLQSFIH | 646 | Q7Z402 | |
| PVSSHSFDSSNVRKP | 1431 | Q70EL1 | |
| SSDSTSGPEKHSILS | 1611 | Q9P2D8 | |
| TFHSKSTLSEPQNNS | 206 | Q9NR11 | |
| FITGSTATKHFLDSS | 201 | Q9UKN1 | |
| SHSATSVFVGEPKTS | 241 | Q9UKN1 | |
| SEKSTIFHSSPDASG | 1186 | Q9UKN1 | |
| SGHSEKSTIFHSSPD | 2266 | Q9UKN1 | |
| KSTIFHSSPDASGTT | 2271 | Q9UKN1 | |
| GLSEKSTTFHSSPRS | 3601 | Q9UKN1 | |
| SEKSTIFHSSPDASG | 3826 | Q9UKN1 | |
| SGLSQESTTFHSKPG | 4931 | Q9UKN1 | |
| LSFQGSKDSPATTHS | 841 | E9PAV3 |